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The number of studies addressing the possible effects of air pollutants on human reproduction, 
especially prenatal outcomes, has grown extensively. However, the plausible biological 
mechanisms by which air pollutants influence prenatal outcomes remain unclear. The aims of 
this dissertation are (1) to determine whether ambient air pollution exposure (including particles 
of less than 10 µm (PM10) and less than 2.5 µm diameter (PM2.5), carbon monoxide, nitrogen 
dioxide, sulfur dioxide, and ozone) contributes to increased inflammatory response by measuring 
C-reactive protein (CRP) concentrations during early pregnancy, and (2) to examine associations 
between ambient air pollution exposures and blood pressure changes during pregnancy. In 
addition, because smoking during pregnancy is a risk factor for some adverse birth outcomes 
such as preterm delivery, and inflammation has been suggested to increase the risk of preterm 
delivery, the other aim of this dissertation was to examine whether systemic inflammation 
mediates the link between smoking and preterm delivery. The study population was selected 
from the Prenatal Exposures and Preeclampsia Prevention study (PEPP) conducted in Pittsburgh, 
PA between 1997 and 2001. Space-time Kriging interpolation for ambient station measures at the 
maternal ZIP code was performed to estimate maternal air pollution exposure. Multiple linear 
and logistic regressions were employed to evaluate associations between air pollution, CRP 
concentrations, and blood pressure changes during pregnancy. Positive associations between 
particulate (both PM2.5 and PM10) and ozone air pollution and elevated CRP concentrations in 
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non-smoking women during early pregnancy were observed. For blood pressure changes, we 
found that first trimester exposure to PM10 and ozone air pollution was associated to increases in 
mean systolic and diastolic blood pressure changes during pregnancy. For smoking and preterm 
study, no evidence that systemic inflammation mediates this association was found. Our findings 
provide some new evidence that associations between particulate air pollution and adverse birth 
outcomes may be mediated by systemic inflammation and blood pressure changes. These 
findings have considerable public health significance to further prevent the adverse birth 
outcomes associated with air pollution exposure. 
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1.0  INTRODUCTION 
Premature birth (gestational weeks < 37) is a major cause of morbidity among neonates and is an 
indicator for impaired organ development that results in adverse health effects in childhood and 
adult life 1-3. The incidence rate of preterm birth was 12.5 percent in 2004 in the U.S. and still 
remains at that level today 4. Although significant efforts to prevent preterm birth have been 
made, poor understanding of underlying pathophysiology is one of the factors hampering its 
prevention and treatment. It has been suggested that intrauterine infection may play an important 
role in developing preterm birth 5,6, and low grade inflammation during pregnancy has been 
related to preeclampsia and preterm birth 7-13. Some occupational and environmental activities or 
exposures have also been related to preterm delivery such as standing jobs 14-16, shiftwork 14-17, 
lead 17,18 and air pollution exposure 19-29. The first study that connected maternal exposure to air 
pollutants and preterm birth was conducted in Beijing, China in 1995 29. This study found that 
mothers who lived in areas with high levels of total suspended particulates (TSP) and sulfur 
dioxide (SO2) during pregnancy had an increased risk of delivering prematurity. Variables 
included in the model included: outdoor temperature and humidity, day of the week, season, 
maternal age, gender of child, and residential area. Since 1995, there have been additional studies 
linking air pollution to the incidence of preterm birth, indicating that exposure to air pollutants 
such as carbon monoxide (CO), nitrogen dioxide (NO2), SO2, ozone (O3), particle diameter less 
than 10 µm (PM10), and particle diameter less than 2.5 µm (PM2.5) in different trimesters are 
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associated with an increased  occurrence of prematurity 22,25-28. However, several other studies 
found no such association 24. Different methods of estimation of the concentration and outcome 
definition may be two of the reasons for inconsistent findings. 
Although most epidemiologic studies suggest that air pollution may play a role in preterm 
delivery, the biological mechanism remains unknown. One hypothesis is that air pollution may 
induce systemic inflammation, which increases the risk of prematurity. This hypothesis has been 
tested in other studies for different populations; however, the results are inconsistent 30,31. To 
date none of the studies has examined the association between air pollution exposure and 
inflammatory responses during pregnancy. The study of air pollution, prematurity and other 
adverse reproductive outcomes is a relatively new area of combining air pollution epidemiology 
with perinatal epidemiology. This area faces several challenges from both disciplines including 
air pollution exposure assessment, identifying an exposure time period, controlling potential 
confounders, and identifying effect-measure modification and selection bias 32. To overcome 
these challenges, an air pollution and human reproductive workshop in Mexico City in 2007 
recommended that applying a consistent analytic strategy and exposure assessment across many 
datasets may reconcile some of the inconsistent findings across studies. Moreover, expanding 
into other birth outcomes or pregnancy conditions, such as gestational hypertension or 
preeclampsia, can provide insights into mechanisms and other adverse outcomes 32. 
1.1 AMBIENT AIR POLLUTION AND PRETERM BIRTH 
Several epidemiologic studies support a link between ambient air pollutant exposure during the 
different trimesters of pregnancy and the risk of preterm birth (table1). Three studies conducted 
3 
in Los Angeles reported an increased risk of preterm birth for high (≥ 75th percentile) 
concentrations of CO exposure during the first month of pregnancy or six weeks before delivery 
26-28. Ritz et al. (2000) reported a 20% increase in preterm birth per an average of 50-µg increase 
in ambient PM10 levels during 6 weeks before delivery (averaged PM10 over the six weeks, 
RRcrude=1.20; 95%CI=1.09-1.33), and a 16% increase risk of preterm delivery over the first 
month of pregnancy (averaged PM10 over the first month of pregnancy, RRcrude=1.16; 
95%CI=1.06-1.26). Wilhelm and Ritz (2005) studied a birth cohort including 146,972 singleton 
children that were born between 1994 and 2000. The study found that maternal exposure to 
higher levels of ambient CO (averaging CO concentrations during the first trimester ≥ 2.1 ppm) 
during the first trimester of pregnancy was associated with a significantly increased risk of 
preterm birth (adjusted relative risk = 1.26; 95% confidence interval (CI), 1.03-1.55). A third 
study included 58,316 infants born in 2003 in Los Angeles and found a similar association. This 
study indicated a 12% increase in preterm birth with higher CO exposure ( averaging CO 
exposure concentrations ≥ 0.91 ppm) during the last 6 weeks of pregnancy 26. Another study 
conducted in California reported that PM2.5 exposure was associated with the effect on preterm 
birth (adjusted odds ratio=1.15, 95% CI, 1.07-1.24) but the effect was not evident in CO 
exposure 22. Similar associations between PM2.5 exposure and preterm delivery were also 
observed in two other studies in California 26,28.  
Internationally, a study conducted by Liu et al. (2003) in Vancouver, Canada, showed a 
small increase in the risk of preterm birth for each 1 ppm increase of CO (odds ratio=1.08; 95% 
CI, 1.01-1.15) and for 5 ppb increase of SO2 (odds ratio=1.09; 95% CI, 1.01-1.19) during the last 
month of pregnancy 25. However, maternal smoking was uncontrolled in this study. Recently, a 
study conducted in Korea found that area-level socioeconomic status (SES) modified the effects 
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of PM10 on preterm delivery 33. They reported that an average increase in PM10 per 10 µg/m3 
during the second trimester of pregnancy was associated with the increased probability of 
preterm delivery (3.1%, 95% CI=0.17 – 6.15) for the entire population and a slightly higher 
probability was observed for the low income area (3.4%, 95% CI=0.31 – 6.58). Moreover, a 
study conducted in Spain reported women exposed to an average NO2 concentrations above 46.2 
µg/m3 during the second, third trimesters, and entire gestation were associated with an increased 
risk of preterm birth 34.  
1.2 AMBIENT AIR POLLUTION AND BIRTH WEIGHT AND LOW BIRTH 
WEIGHT (LBW) 
Epidemiological evidence links ambient air pollution exposure and the risk of low birth weight 
(LBW, birth weight <2,500g) in different trimesters of pregnancy (table2). Two studies 
conducted in Los Angeles reported a lower mean birth weight for babies whose mothers lived in 
areas of higher concentrations of CO during the third trimester of pregnancy 28,35. In the Ritz and 
Yu study, the birth cohort was born between 1983 and 1993, including 125,573 singleton 
children. The study found that maternal exposure to higher levels of ambient CO (> 5.5 ppm) 
during the last trimester of pregnancy was associated with significantly increased risk of LBW 
(OR=1.22; 95% confidence interval (CI), 1.02-1.44). The second study included 146,972 infants 
born between 1994 and 2000 in Los Angeles and found the same association. This study 
indicated a 36% increase in LBW during high CO exposure (≥ 1.82 ppm) in the third-trimester of 
pregnancy 28. However, the two studies were limited by their inability to control for maternal 
smoking and pregnancy weight gain, significant contributors to the risk of delivering at LBW. 
5 
Another study conducted in the United States examined the association between ambient air 
pollution and LBW in the cities of Boston, Hartford, Philadelphia, Pittsburgh, Springfield, and 
Washington 36. The study found that maternal exposure to both CO and SO2 in the second and 
third trimesters was associated with reduced birth weight 36. Further, the study showed that with 
every increase of 1ppm of CO exposure in the third trimester, the risk of LBW was increased 
(adjusted OR 1.31; 95% CI, 1.06-1.62). 
Internationally, two studies in Seoul, Korea also found that maternal exposure to CO, 
SO2, and NO2 during the beginning or middle of pregnancy had adverse effects on birth weight 
21,23. The first study, completed by Ha et al. (2001), showed a small increase in the risk of LBW 
for each inter-quartile increase of CO (adjusted relative risk 1.08; 95% CI=1.04-1.12) in the first 
trimester. Also, this study indicated a negative relationship between birth weight and 
concentrations of NO2, SO2, and total suspended particle (TSP). This relationship was relatively 
linear, without thresholds for concentrations of the pollutants 21. However, maternal smoking 
was uncontrolled in these two Korea studies. Another study, completed by Gouveia and 
colleagues, reported that a reduction of 23 g in birth weight was estimated for a 1 ppm increase 
in mean exposure to CO during the first trimester. Again, this study was unable to control for 
maternal smoking and weight gained during pregnancy. 
Several studies do not support an association between ambient air pollution and LBW. 
Alderman et al. (1987) was the first study examining air pollution and LBW in Denver, 
Colorado. This study did not find an association between higher CO exposure and higher risk of 
LBW. The bias in this study was that the local variation in CO concentration was not 
incorporated from stationary monitors due to small variations 37. They also did not control for 
maternal smoking. Thus, they recommended that further studies would likely require direct 
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measurement of total CO exposure, which includes indoor and workplace CO exposure. Another 
study conducted in California found that higher PM2.5 exposure increased the risk of small for 
gestation age (SGA) 38. However, they did not find a link between CO exposure and LBW which 
is the combination of preterm birth and IUGR. This finding varied from the two other studies 
described previously conducted in California 28,35. The disparity in results could possibly be 
because of differences in the measures of CO exposure. Another study in Northern Nevada also 
did not find a link between air pollution exposure and LBW 39. This study examined 39,338 
singleton births in Washoe County from 1991 through 1999. However, CO was not found to be 
associated with birth weight through logistic regression after control for infant sex, city of 
residence, education, medical risk factors, active tobacco use, drug use, alcohol use, prenatal 
care, age, race, ethnicity, and maternal weight gain. In Vancouver, Canada, no association 
between CO exposure, and LBW was found 25. However, preterm birth was associated with CO 
during the last trimester of pregnancy and the odd ratios for 1 ppm increase of CO was 1.08 (95 
% CI, 1.01-1.15). Inability to control maternal smoking was the common limitation for many of 
these studies 37-39. 
1.3 AMBIENT AIR POLLUTION, INTRAUTERINE GROWTH RETARDATION, 
GESTATIONAL HYPERTENSION AND PREECLAMPSIA 
Most perinatal air pollution studies examined the effects of air pollution on LBW and preterm 
birth. However, few studies have examined the relationship between air pollution exposure and 
intrauterine growth retardation (IUGR), gestational hypertension and preeclampsia (table3). 
Small for gestational age (SGA, as a marker of IUGR) infants is defined as <10th percentile of 
7 
birth weight for gestational age and sex. Bobak et al. (2000) examined associations between SO2, 
TSP, and NOx and IUGR, and found no significant associations between pollutant 
concentrations and IUGR after controlling for sex, parity, maternal age group, education, marital 
status and nationality, and month of birth (table3). Liu et al. (2003) examined the association 
between SO2, NO2, CO and O3 air pollution and IUGR. They reported that first month of 
pregnancy exposure to higher SO2 (OR=1.07, 95% CI=1.01-1.13, for a 5.0 ppb increase), NO2 
(OR=1.05, 95% CI=1.01-1.10, for a 10 ppb increase) and CO (OR=1.06, 95% CI=1.01-1.10, for 
a 1.0 ppm increase) was associated with IUGR. 
A study assessed the relationship of hazardous air pollutants on adverse pregnancy 
outcomes and reported a significant protective effects of some hazardous air pollutants on 
preeclampsia or gestational hypertension, such as acetaldehyde (OR=0.5, p<0.01), arsenic 
(OR=0.6, p<0.01), benzene (OR= 0.1, p<0.0001), chromium (OR=0.6, p<0.0001), formaldehyde 
(OR=0.3, p<0.0001), mercury (OR=0.2, p<0.001) and nickel (OR=0.5, p<0.0001) 40. However, 
Williams (2006) reported a non-significant relationship between CO air pollution and risk of pre-
eclampsia (RR=1.73, 95% CI=0.91-3.27 for third tertile exposure vs. first tertile) 41.  
1.4 EXPOSURE ASSESSMENT FOR AMBIENT AIR POLLUTION 
Assessment of maternal exposure to air pollution has many challenges. Most of the previous 
studies used ZIP-code-level analysis, incorporating air monitoring station data or constant 
distance from the air monitor to determine levels of exposure for mothers 28,42,43. Such methods, 
however, may entail certain degrees of exposure misclassification bias and such bias could 
ultimately lead to an overestimation or underestimation of the true effects 44. A few studies 
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estimated individual exposure to ambient air pollution by modeling from air monitoring stations 
to a geographically identified receptor (location), through the use of an environmental transport 
model, or block Kriging statistical mapping technique, which can predict an average 
concentration over a spatial region from point locations 45,46. These methods, which specified the 
individualized environmental exposures, largely reduce the misclassification bias. Therefore, 
they are considered better than the ZIP-code-level analysis and constant distance from the air 
monitoring station.  
Two studies conducted in Denver and Los Angeles 35,37 used mean air pollution 
concentrations measured from air monitoring stations and examined the mothers who were 
residing in the census block or ZIP-code area within a 2-mile radius of stations to examine the 
associations with birth weight. The median CO exposure levels reported for Denver ranged from 
0.5 to 3.6 ppm, and the 50-95-percentile exposure levels for Los Angeles were 2.2 to 5.5 ppm. 
Wilhelm and Ritz (2005) estimated exposure levels by calculating the distance to the nearest air 
monitors, and they suggested that the effects manifested during the first and second trimester as 
the result of CO concentrations for mothers who resided within a 1 mile distance of monitors. 
Another series of studies that examined associations between CO and birth weight also relied on 
ambient measurements of the CO air pollutant for exposure estimates 20,21,23,25,36,37,39. These 
studies assigned mean concentrations of different ambient air pollutants to mothers who lived 
within the same cities as the stations. Mean exposure levels within each trimester were calculated 
by averaging daily ambient air pollution concentrations during the corresponding days. 
Due to data availability and privacy issues, individual geographic location is not easily 
obtainable from the birth registry dataset. However, two studies conducted in California were 
able to obtain personal levels of information such as coordinates and addresses to identify the 
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residence of mothers 28,38. In addition, both studies were able to calculate the exact distance from 
maternal residence to the nearest air monitoring stations. Although the studies were capable of 
estimating the distance to each of the stations, personal exposure concentration still could not be 
obtained from monitoring data. 
Among modeling techniques, the environmental transport model, which is based on the 
Gaussian plume atmospheric transport model, was used by Rogers and Dunlop (2006) to 
estimate PM10 exposure at the scale of the individual address. The annual PM10 emissions were 
measured from air monitoring stations and industrial point sources. The Gaussian plume 
atmospheric transport models assume that plume concentration has independent Gaussian 
distributions in horizontal and vertical planes at each downwind distance 47,48. This model is 
widely used to predict concentrations in the atmosphere and is recommended by the US EPA 49. 
Although the environmental transport model had been validated elsewhere 50, the primary 
limitation involves the uncertainties in the model, such as release quantities, the transport model, 
ambient temperature, wind speed and direction, and stack gas temperature and velocities 46.  
As another interpolation method, Kriging is a weighted average technique used to estimate a 
smooth surface from data points over the domain and predicts the average block based on regular 
grids. Additionally, cross-validation, “a technique with which each monitoring station is 
removed, one at a time, and the concentration at each omitted station is predicted using the 
concentration values observed at the other monitors,” is used to evaluate the quality of the 
predicted values from Kriging. The first study to use the Kriging statistical mapping technique 
on evaluation air pollution and preterm delivery was presented by Leem et al. (2006). They used 
0.17 km * 0.17 km grids to partition each dong (the administrative unit in Korea similar to a 
county) for each pollutant and each month. They found the Kriging technique provided 
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reasonable results for surface interpolation of pollutants concentrations, such as CO, SO2, NO2, 
and PM10. Because this method is fairly accurate and avoids the artifacts that often result from 
the use of inverse distance weighted, spline, or global/local polynomials, its use for predicting 
the spatial distribution of air pollutants was one of the strengths of this study 27,51. However, they 
still were not able to control for maternal smoking, its potential misclassification of exposure due 
to the use of surrogate ambient air pollution data, the uncertainty of the predicted average 
concentrations for the dongs, and its inability to geocode the residential addresses to point 
locations. 
1.5 BIOLOGICAL MECHANISM OF AIR POLLUTION AND BIRTH OUTCOMES 
Possible biological mechanisms by which air pollutants may influence birth outcomes have been 
suggested but few of them have been examined. Oxidative stress may induce DNA damage 
which may increase the number of placental DNA adducts 52. Particulate air pollutants, such as 
PM10, that are made up of absorbed polycyclic aromatic hydrocarbon (PAHs) may lead to DNA 
adducts, thus resulting in LBW and IUGR 53-56. One hypothesis suggests that air pollution-
induced inflammatory processes may cause preterm birth or IUGR by altering maternal 
immunity 57. Maternal immunity may be altered by exposure to air pollutants which may induce 
inflammatory processes and increased susceptibility to infections 57. In addition, 
proinflammatory cytokine genes were found to be associated with spontaneous preterm birth 58. 
Although air pollution does not directly cause maternal infections, evidence on air pollution-
induced inflammatory process may influence maternal immunity and increase the risk for 
adverse birth outcomes. 
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The binding of CO with hemoglobin to produce elevated levels of HbCO in smokers, 
decreasing the oxygen available to the fetus might be a possible mechanism for the negative 
impacts that smoking during pregnancy has on LBW 59. In 1857, Claude Bernard first observed 
that carbon monoxide had greater affinity for binding to hemoglobin (Hb) than oxygen. As a 
result, the oxygen tension of blood decreases to lower than normal values. This effect may be 
particularly significant for the fetus since the oxygen partial pressure in its arterial blood is 
normally relatively low (about 20 to 30 mmHg) in the fetus as compared to adult values of about 
100 mmHg 60. In addition, fetal Hb has greater affinity for CO than maternal Hb, the half-life of 
carboxyhemoglobin (COHb) in fetal blood is three times longer than that of maternal blood, and 
the fetus has a higher rate of oxygen consumption than mothers. Thus, maternal COHb 
concentration has a great influence on the fetus’ COHb since CO crosses the placenta by simple 
diffusion and binds to Hb forming COHb in the red blood cell stroma 61. Wouters et al (1987) 
examined fetal outcomes and HbCO levels in the umbilical cords of 77 uneventful pregnancies. 
They found that HbCO levels were significantly elevated in the venous cord blood of children of 
smokers compared to non-smokers 62. This research provides evidence for biological 
mechanisms for smoking or ambient CO exposure on LBW. 
1.6 AIR POLLUTION AND INFLAMMATORY MARKERS 
Epidemiological studies suggest that exposure to higher levels of air pollution, especially 
particulate matter (PM) air pollution, is associated with increased cardiovascular and pulmonary 
mortality and morbidity. Studies have investigated the underlying pathophysiology mechanisms, 
and one hypothesis is that inhaled particulates lead to pulmonary inflammation, which causes the 
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release of inflammatory mediators into the bloodstream. These mediators may influence 
hemostasis and increase blood coagulation, therefore, increasing the risk of cardiopulmonary 
disease.  Markers of inflammation, such as interleukin-6 (IL-6), interleukin-8 (IL-8), tumor 
necrosis factor-α (TNF-α), C-reactive protein (CRP), fibrinogen, and white cell counts, have 
been studied to test this hypothesis (table4). CRP, an acute-phase protein and a sensitive marker 
of inflammation and infection, has demonstrated the strongest biomarker response to air 
pollution exposure and the inflammation response in humans. 
Seaton et al. (1999) reported a negative association between PM10 exposure and 
fibrinogen concentration. They also observed a 147% (95%CI=20%-477%) increase in CRP for 
an average 3 days per 100 µg/m3 increase in PM10 exposure 63. Peter et al. (2001) reported on the 
impact of SO2, CO, and total suspended particulates (TSP) air pollution on CRP in a sample of 
631 men aged from 45 to 64 years 64. They observed that the odds of increasing CRP levels were 
associated with both SO2 and TSP, but not CO; however, the effects for TSP were generally 
stronger than SO2. They also found that estimates from the 5 days mean exposure had slightly 
stronger effects on CRP, which suggest a 5 day cumulative effect of particles on CRP. The odds 
ratio for observing a CRP concentration above the 90th percentile (above 5.7 mg/l) for a 5 day 
mean of TSP (increase of 26 µg/m3)  and SO2 were 1.46 (95%CI=1.17-1.82) and 1.24 
(95%CI=1.03-1.49), respectively.  Another study examined the relationship between particulates 
air pollution and inflammatory markers among 710 healthy men 65. The study found a positive 
association between CRP and particulate air pollution, and presented that a 4.36% (95%CI=-3.25 
to 11.96) increase in CRP was associated with a one standard deviation (SD) increase in 4 weeks 
PM2.5 exposure.  
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Children, elderly, and sick people are more susceptible to the effects of air pollution 
exposure. Children and infants are particularly sensitive as their total lung volume is so much 
smaller, increased respirations result in greater exposure. Similarly, pregnancy is a period of 
dramatic changes in maternal anatomy, physiology, and metabolism to support the development 
of the fetus which may be more susceptible to air pollution. Pope et al. (2004) studied the PM’s 
influence on cardiac autonomic function and markers of inflammation among 88 elderly subjects 
(age between 54-89 years) 66. They found that PM2.5 was not significantly associated with white 
or red blood cell counts, platelets, or blood viscosity, but they observed a 100 µg/m3 increase in 
PM2.5 was associated with a 0.81 mg/dL increase in CRP. Another study examined the effects of 
air pollution and inflammation response by studying 158 asthmatic and 50 non-asthmatic 
children aged from 6 to 14 years. They also reported that PM2.5, NO2, and O3 were associated 
with inflammatory responses in both asthmatic and non-asthmatic children 67. Two studies 
examined air pollution and inflammation markers by studying the participants with coronary 
heart disease or with a history of coronary heart disease 68,69. They both have consistent findings 
of  positive associations between concentration of biomarkers and air pollution exposure.  
Recently, two large studies evaluated the effect of exposure to air pollution on 
inflammatory markers in healthy individuals. Although one study evaluated short term exposure 
and the other evaluated long term exposure, both reported no significant correlations between air 
pollution and inflammatory markers. This result may indicate that long term exposure to outdoor 
air pollution is not associated with cardiovascular risks, which is mediated by chronic systemic 
inflammation 30,31.  
A recently study by Williams et al. (2009) examined the proximity to traffic and 
inflammation among 115 postmenopausal overweight women 70. This study hypothesized that 
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living near major roads would be associated with increased inflammation. However, they did not 
find any increase risk of inflammation for those women who lived within 150 m of major roads. 
The exposure assessment in this study relied on the distance to the roads and assumed the same 
amount of exposure every day. This may not capture background air pollution or personal 
exposure, which may account for the null findings. 
1.7 C-REACTIVE PROTEIN DURING PREGNANCY 
CRP is an acute phase protein generated by the liver, and its levels in the blood can rise up to 
1000-fold in the presence of injuries, trauma and infection 71. Obesity, estrogen use, smoking, 
race, and ethnicity have been reported to be associated with subclinical elevations in serum CRP 
10,72-74, but the concentrations of CRP are generally  low for people without infection. In addition, 
pregnant women have higher CRP concentrations than non-pregnant women 75. The increased 
CRP concentrations during pregnancy may support the notion that pregnancy is associated with a 
pro-inflammatory state and reflect maternal response to inflammation (table5).  However, the 
exact etiology of this increase is still unknown.  
Maternal CRP concentrations are raised as early as at 4 weeks gestation 75. Larsson et al. 
(2008) report that the lower (2.5 percentile) and upper limits (97.5 percentile) of CRP between 7-
17 weeks were 0.32-11.91 (mg/L) 76. The study followed 52 healthy women and showed that 
CRPs increased as the number of gestational weeks increased and then dropped substantially 
(lower and upper limits were 0.23-7.60 mg/L) within 6 days postpartum. Fialova et al. (2006) 
present similar findings, and demonstrating that maternal CRP levels of pregnant women 
gradually increase during the 1st and 2nd trimesters (p<0.05) 77. However, Cicarelli et al. (2005) 
15 
observed maximum CRP concentrations at 24 hours postpartum (5.8±3.6 for vaginal delivery 
(VD); 11±5.3 for Cesarean section delivery (CD)), which is inconsistent with Larsson et al.’s 
findings 78. One possible explanation is that both studies collected blood samples at different 
time periods after delivery. One measured CRP within 6 days of postpartum while the other 
measured CRP at 24 hours postpartum. Besides, Cicarelli et al. stratified their analysis by 
delivery type (vaginal delivery vs. Cesarean section) and they also found that there is a difference 
in CRP between VD and CD (p=0.01) after 24 hours and after 60 hours.  
Maternal serum CRP has been reported to be significantly higher than newborn’s 79. 
Hackney et al. (2008) examined the association between maternal and fetal variation in CRP 
genotype and maternal plasma CRP concentrations in the first trimester among 190 mother-baby 
pairs. They were unable to find relationships between maternal plasma CRP and CRP genotype, 
and suggest that clinical factors may have more influence on maternal CRP concentrations. 
1.8 CRP AND PRETERM DELIVERY 
Preterm birth (defined as gestational weeks <37) is the leading cause of infant morbidity and 
mortality 4. The incidence of preterm birth was 12.5 percent in 2004 in the U.S. and still 
increased today. One of the reasons however, is the increase in multiple births, increase in 
elective C-section and other medical interventions in addition to personal risk factor such as 
maternal age at delivery. Although significant efforts to prevent preterm birth have been made, 
poor understanding of underlying pathophysiology is one of the factors hampering its prevention 
and treatment. It has been suggested that intrauterine infection may play an important role in 
developing preterm birth 5,6, and low grade inflammation during pregnancy has been related to 
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preeclampsia and preterm birth 7-13 (table6). Pitiphat et al. (2005) examined the association 
between maternal plasma CRP concentrations in early pregnancy (5.3-19.3 weeks’ gestation) and 
the risk of preterm delivery 11. They reported an odds ratio of preterm delivery for a CRP 
concentration of at least 8 mg/L (vs. <8 mg/L) was 2.55 (95%CI=1.05-6.20), and the odds ratio 
of preterm delivery for a CRP concentration of at least 12 mg/L (vs. <12 mg/L) was 3.19 
(95%CI=0.98-10.32) after controlling for gestational age at blood collection, gravidity, 
pregnancy BMI, genitourinary infection, maternal employment, annual household income, 
physical activity, and alcohol consumption during the first trimester. Subsequent studies report 
similar findings.  
Lohsoonthorn et al. (2007) conducted a nested case-control study to examine the 
relationship between maternal early serum CRP (13 weeks’ gestation) and preterm delivery in 
146 preterm cases and 1623 term delivery controls. They presented the odds ratio of preterm 
delivery for highest quartile (≥7.5 vs. <2.0 mg/L) of CRP was 2.04 (95%CI=1.13-3.69) 80. Catov 
et al. (2007) also reported 2.6- to 2.8-fold increase risks of preterm delivery for early pregnancy 
inflammation (CRP ≥ 8 µg/ml) 81. This study also examined the relationship between 
dyslipidemia, inflammation and spontaneous preterm birth. They presented an independent effect 
of inflammation and dyslipidemia on the risk of spontaneous preterm birth.  However, the study 
conducted by Ghezzi et al. (2002) was unable to find any association between CRP 
concentrations and preterm delivery 82. The study concluded that maternal blood CRP 
concentrations were not associated with preterm delivery. However, they reported that women 
with preterm delivery at <34 weeks or <37 weeks had a higher median of amniotic fluid CRP 
concentrations than women with term delivery. Moreover, Boggess et al. (2005) conducted a 
nested case-control study among 44 cases (spontaneous abortion or fetal loss < 21 weeks 
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gestation) and 88 controls (full-term births), and reported a decrease risk of pregnancy loss 
(OR=0.20, 95%CI=0.06-0.65) for women with CRP concentrations greater than the 75th 
percentile 83. 
1.9 SUMMARY 
Over the last 15 years, numerous studies in the United States and elsewhere have reported a 
positive relation between air pollution and birth outcomes such as low birth weight, preterm 
birth, and intrauterine growth retardation. Most studies examined the association between air 
pollution and birth outcomes showed that ambient air pollution seems to play some role in 
determining birth weight or gestational week. However, the differences in study outcomes and 
pregnancy periods studied result in the studies undergoing continued debate 28. One reason for 
this debate is because unknown biological mechanism of air pollution effects on birth outcomes.  
 Estimating environmental exposure to ambient air pollution is another challenge in 
epidemiology studies. Most of the studies rely on crude methodologies obtained from air quality 
monitoring data by sampling networks and assigning a crude estimate of exposure in large 
population areas such as cities, counties, census blocks, and postal ZIP code areas 50. These types 
of ecological studies ignore the location of pollutant sources and the atmospheric influence on 
concentrations of pollutants. As a result, these ecological studies poorly identify the mothers as 
exposed or unexposed. Recently, many studies have incorporated modeling techniques, such as 
the environmental transport model and/or GIS spatial modeling techniques to improve the 
exposure assessment method and to reduce the misclassification present in previous studies, 
which assigned a crude estimate of exposure to large population. 
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Preterm birth is an important issue in reproductive health because of its influences on the 
fetus’ health outcomes in later life. Environmental exposure may play a role in the risk of 
reduced birth weight and gestational period, especially air pollution exposure. Although many 
epidemiological studies have linked air pollution exposure to preterm birth, the evidence on 
plausible biological mechanisms is still unclear. It has been suggested that intrauterine infection 
may play an important role in developing preterm birth 5,6, and low grade inflammation during 
pregnancy has been related to preeclampsia and preterm birth 7-13. CRP, proinflammatory 
cytokines interleukin (IL)-1, and IL-6 are the most widely studied biomarkers of inflammation 84. 
Although CRP is one of the major acute-phase proteins in humans 85, it has been shown to 
predict cardiovascular diseases 86,87 and has been found to be associated with particulate matter 
(PM) air pollution 63,64,66,88. Thus, the results of my study which examines the association 
between air pollutant exposure and inflammation during pregnancy may provide evidence of 
biological mechanisms by which in air pollution exposure in pregnancy results in adverse 
outcomes.  
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1.10 TABLES 
Table 1. Ambient air pollution and preterm delivery 
Author Study 
Population 
Outcomes 
definition 
Air Pollution 
Studied 
Exposure 
Assessment 
Effect Period Outcomes Controlling Factors 
Ritz et al. 
(2000) 
A cohort of 
97,518 
 Vaginally 
delivered 
preterm births 
 C-Section 
delivered 
preterm births 
 Excluding 
subjects 
considered SGA 
or LBW 
 Restricting 
preterm births 
to SGA or LBW 
children 
CO, PM10, 
NO2, and 
ozone 
ZIP code 
within 2 
miles of 
monitoring 
stations 
 6 weeks before 
delivery 
 First month of 
pregnancy 
Results from crude model: 
A 20% increase in preterm 
birth per 50-µg increase in 
ambient PM10 levels over 6 
weeks before delivery 
(RRcrude=1.20; 95%CI=1.09-
1.33), and a 16% increase 
risk of preterm delivery over 
the first month of pregnancy 
(RRcrude=1.16; 95%CI=1.06-
1.26). 
Gender, prenatal care, 
parity, time to previous 
livebirth≥12 months, 
maternal race, education, 
age, tobacco use during 
pregnancy and 
pregnancy history 
Wilhelm 
and Ritz 
(2005) 
146,972 
births 
Vaginal birth <37 
completed weeks 
gestation 
CO, PM10, 
PM2.5, NO2, 
and ozone 
ZIP code and 
personal 
level/various 
distance to 
monitoring 
stations 
 6 weeks before 
delivery 
 First month of 
pregnancy 
Results from single pollutant 
model: 
  A 26% increase in preterm 
birth for exposure to greater 
than 2.1 ppm of CO 6 weeks 
before delivery 
(RRadjusted=1.26; 
95%CI=1.03-1.55), 
Results from multi-pollutant 
model: 
  A 27% increase risk for 
high (≥ 75th percentile) first 
trimester CO exposure. 
Infant sex, maternal age, 
race, and education, 
interval since previous 
live birth, previous LBW 
or preterm birth, level of 
prenatal care, birth 
season, and parity 
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Table 1 (continued)  
Ritz et al. 
(2007) 
58,316 
birth cohort 
and 2,543 
women 
<37 weeks of 
gestation 
CO, NO2, 
O3 and PM2.5 
ZIP code level/ 
nearest 
monitoring 
stations 
6 weeks 
before 
delivery 
 
Results from crude model: 
  A 12% increase in preterm 
birth with higher CO exposure 
(≥ 0.91 ppm) during the last 6 
weeks of pregnancy. 
Birth season, parity, and 
mother’s age, race, and 
education 
Huynh et 
al. (2006) 
10,673 
preterm 
births and 
32,019 
term births 
Between 24 and 
36 weeks’ 
gestation 
CO and 
PM2.5 
5 miles of PM 
monitors 
Entire 
pregnant 
period 
PM2.5 exposure (>22.1 µg/m3) 
was associated with the effect on 
preterm birth (adjusted odds 
ratio=1.15, 95% CI, 1.07-1.24). 
Maternal age, race, 
maternal education, 
marital status and parity 
Bobak et 
al. (2000) 
A cohort of 
108,173 
<37 weeks of 
gestation 
SO2, TSP, 
NOx 
District-base/ 
mothers living 
within the same 
area as 
monitoring 
stations 
In the first 
trimester 
Results from single pollutant 
model: 
The adjusted ORs per 50 µg/m3 
increase during the first trimester 
were 1.27 (95%CI=1.16-1.39) 
for SO2; 1.18 (95%CI=1.05-
1.31) for TSP; and 1.10 
(95%CI=1.00-1.21) for NOx. 
Sex, parity, maternal age 
group, education, marital 
status and nationality, 
and month of birth 
Xu et al. 
(1995) 
25370 
women 
<37 weeks of 
gestation 
SO2, TSP Four residential 
areas of Beijing/ 
mothers living 
within the same 
area as 
monitoring 
stations 
Entire 
pregnant 
period 
Results from single pollutant 
model: 
  The adjuster ORs per one log-
transform unit increase in SO2 
was 1.21 (95%CI=1.01-1.46) 
and the adjusted ORs per 100 
µg/m3 increase in TSP was 1.10 
(95%CI=1.01-1.20). 
Quintiles of temperature, 
quintiles of humidity, 
day of the week, season, 
residential area, maternal 
age, and gender of child 
Liu, et al. 
(2003) 
229,085 
singleton 
live births 
<37 weeks of 
gestation 
SO2, NO2, 
CO and O3 
Provincial 
census 
subdivision/ 
proximity to air 
monitoring 
stations 
Last month 
of 
pregnancy 
Results from multi-pollutant 
model: 
  Exposure to SO2 and CO in the 
last month of pregnancy was 
associated with increased risk of 
preterm birth (OR=1.09, 
95%CI=1.01-1.20 for SO2; 
OR=1.08, 95%CI=1.00-1.20 for 
CO).  
Maternal age, parity, 
infant sex, birth weight, 
and season of birth 
SGA: small for gestational age; LBW: low birth weight; TSP: total suspended particles 
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Table 2. Results of studies of ambient air pollution and low birth weight 
First author 
(year) 
Outcome and exposure measures Exposure categories Odds ratio/changing in birth 
weight (g) (95% CI) 
Rite  
(1999) 
LBW and mean concentrations of CO 
in third trimester of pregnancy 
Divided CO mean concentrations into three categories (< 
50th, 50 to < 95th,  95th percentile)  
<50th  vs. >95th percentile 
 
 
1.22 (1.03-1.44) 
Ha 
(2001) 
LBW, and mean concentrations of CO, 
O3, SO2, NO2, and TSP in first and 
third trimesters of pregnancy 
1.Divided CO, O3, SO2, NO2, and TSP mean 
concentrations into quartiles, 
each quartile increased 
    CO 
    SO2 
    NO2 
    TSP  
2.Served pollutants as continuous variables 
    CO per 100 ppb increased 
    SO2 per 1 ppb increased 
    NO2 per 1 ppb increased 
    TSP per 50.0 μg/m3 increased 
 
 
 
1.08(1.04-1.12) 
1.06(1.02-1.10) 
1.07(1.03-1.11) 
1.04(1.00-1.08) 
 
11.55(8.99-14.10) 
8.06(5.59-10.53) 
8.41(6.07-10.76) 
6.06(3.85-8.27) 
Maisonet 
(2001) 
LBW and mean concentrations of CO, 
PM10, and SO2 in each trimester of 
pregnancy 
Divided CO, PM10, and SO2 mean concentrations into five 
categories (< 25th, 25th  to < 75th, 75th to < 95th,  95th 
percentile) 
  < 25th vs  95th percentile 
     CO 
     SO2 
Served pollutants as continuous variables 
     CO per 1 ppm increase 
 
 
 
 
1.15(0.94-1.42) 
1.06(0.76-1.47) 
 
1.31(1.06-1.62) 
Lee  
(2003) 
LBW and mean concentrations of CO, 
SO2, NO2, and PM10 in each trimester 
and month of pregnancy 
Divided CO, O3, SO2, NO2, and PM10 mean concentrations 
into quartile for each quartile increase 
  CO 
  SO2 
  NO2 
  PM10 
 
 
1.05(1.01-1.09) 
1.14(1.04-1.24) 
1.04(1.00-1.08) 
1.06(1.01-1.10) 
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Table 2 (continued)  
 Gouveia 
(2004) 
LBW and mean concentrations of PM10, 
CO, SO2, NO2 and O3 in each trimester 
of pregnancy 
1.Divided PM10, SO2, and O3 mean concentrations into 
quartiles (< 25th, 25th to 50th, 51st  to 75th , > 75th 
percentile) 
<25th vs >75th percentile 
    PM10 
    CO 
2.Served pollutants as continuous variables 
  CO per 1.0 ppm increase 
  PM10 per 10.0 μg/m3 increase 
 
 
 
 
1.14(0.87-1.49) 
1.02(0.82-1.27) 
 
-23.1(-41.3 to -4.9) 
-13.7(-27.0 to -0.4) 
Wilhelm 
(2005) 
LBW, preterm births, and mean 
concentrations of CO, PM10, and PM2.5, 
in third trimester of pregnancy 
Divided CO, PM10, and PM2.5 mean concentrations into 
three categories (< 25th, 25th to < 75th, and  75th 
percentile) 
Served pollutants as continuous variables 
CO per 1 ppm increase 
PM10  45.1 μg/m3 
 
 
 
 
1.12 (1.05-1.19) 
1.12 (0.91-1.38) 
a infants who are below the 10th percentile of birth weight for gestation week
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Table 3. Ambient air pollution and intrauterine growth retardation (IUGR) 
Author Study 
Population 
Outcomes 
definition 
Air 
Pollution 
Studied 
Exposure 
Assessment 
Effect Period  Outcomes Controlling Factors 
Bobak 
et al. 
(2000) 
A cohort of 
108,173 
<10th percentile of 
birth weight for 
gestational age and 
sex (SGA) 
SO2, TSP, 
NOx 
District-base NA No significant associations between 
pollutant concentrations and IUGR. 
Sex, parity, maternal 
age group, education, 
marital status and 
nationality, and 
month of birth 
Liu, et 
al. 
(2003) 
229,085 
singleton 
live births 
<10th percentile of 
birth weight for 
gestational age and 
sex (SGA) 
SO2, NO2, 
CO and 
O3 
Provincial census 
subdivision/ 
proximity to air 
monitoring 
stations 
First month of 
pregnancy, 
first and 
second 
trimester 
Results from single pollutant model: 
  First month of pregnancy exposure to 
SO2 (OR=1.07, 95% CI=1.01-1.13, for 
a 5.0 ppb increase), NO2 (OR=1.05, 
95% CI=1.01-1.10, for a 10 ppb 
increase) and CO (OR=1.06, 95% 
CI=1.01-1.10, for a 1.0 ppm increase) 
was associated with IUGR. 
Maternal age, parity, 
infant sex, birth 
weight, and season of 
birth 
SGA: small for gestational age 
LBW: low birth weight 
TSP: total suspended particles 
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Table 4. Research on air pollution and inflammation markers 
Author Study Population Exposure 
Assessment 
Markers Air 
Pollutants 
Results Adjusted Variables Including 
Current 
Smoking 
Steinvil 
et al. 
(2008) 
3,659 healthy 
subjects (exclude 
pregnancy 
women) 
Within 11 km of 
the nearest 
monitoring 
station (short-
term exposure) 
WBC, 
Fibrinogen, 
and hs-CRP 
PM10, SO2, 
NO2, CO, 
and O3 
No significant correlations 
were found between air 
pollution and inflammation 
markers. 
age, waist circumference, body mass 
index (BMI), complete lipid profile 
including low-density lipoprotein (LDL), 
highdensity lipoprotein (HDL), and 
triglycerides, diastolic and systolic blood 
pressure measurements, glucose 
concentration, alcohol consumption, sport 
intensity etc.a 
Yes 
Brraza-
Villarreal 
et al. 
(2008) 
158 asthmatic and 
50 non-asthmatic 
children 
Nearest 
monitoring 
station (short-
term exposure) 
FeNO, pH of 
exhaled breath 
condensate, 
and IL-8 
PM2.5, NO2, 
and O3 
PM2.5, NO2, and O3 were 
associated with inflammatory 
responses in both asthmatic and 
non-asthmatic children. 
sex, body mass index, previous day 
minimum temperature and chronological 
time 
No (but 
including 
parental 
smoking) 
Forbes et 
al. (2009) 
about 25,000 
adults with 
fibrinogen 
measurements and 
17,000 adults with 
CRP 
measurements 
Air dispersion 
model at 
postcode sector 
level (Long-
term exposure) 
Fibrinogen, 
and CRP 
PM10, SO2, 
NO2, and O3 
No significant associations 
between concentrations of 
fibrinogen or CRP and outdoor 
air pollution (PM10, SO2, NO2, 
and O3) 
age, sex, body mass index (and their 
interactions), social class of head of 
household, cigarette smoking, region, 
month of nurse visit, and indoor 
temperature (only in 1998 and 2003) 
Yes 
Delfino et 
al. (2008) 
29 nonsmoking 
elderly subjects 
with a history of 
coronary artery 
disease 
Direct measure 
indoor and 
outdoor 
pollutants 
(short-term 
exposure) 
CRP, 
Fibrinogen, 
TNF-α, sTNF-
RII, IL-6, IL-
6sR, fibrin D-
dimer, sP-
selectin, 
sVCAM-1, 
sICAM-1, and 
MPO 
Outdoor: 
NO2, CO, 
O3, EC, OC, 
BC, OCpri, 
OCsec, and 
PN, PM0.25-10 
Indoor: NO2, 
CO, EC, 
OC, OCpri, 
OCsec, PN, 
and PM0.25-10 
Positive association for CRP, 
IL-6, and sTNF-RII with PM ≤ 
0.25 µm, EC, OCpri, BC, PN, 
CO and NO2. 
NA  No 
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Table 4 (continued)  
Rückerl 
et al. 
(2006) 
57 male patients 
with coronary 
heart disease 
Based on one 
fix air 
monitoring  
station (short-
term exposure) 
CRP, SAA, 
Factor VII, 
vWf, 
Fibrinogen, 
prothrombin 
fragments 
1+2, D-dimer, 
ICAM-1, and 
E-selectin 
UFPs, AP, 
PM2.5, PM10, 
OC, EC, 
NO2, and 
CO 
CRP and ICAM-1 were 
associated with ambient air 
particles. The odds ratio for 
observing a CRP concentration 
above 90th percentile (above 
8.5 mg/l) for a 5 days mean of 
PM10 (interquartile range) was 
2.0 (95%CI=1.20-3.70). 
NA No 
Williams 
et al. 
(2009) 
115 
postmenopausal, 
overweight 
women 
Distance to 
major road 
CRP, SAA, 
IL-6, NK cell 
cytotoxicity, 
and T-
lymphocyte 
proliferation 
Traffic 
related air 
pollution 
CRP, SAA, IL-6, and 
lymphocyte proliferation did 
not differ according to 
proximity to major roads.  
age, BMI, education (individual-level), 
season of enrollment, time spent 
outdoors, and median income in the 
census tract of residence. 
No 
Pope et 
al. (2004) 
88 elderly subjects Nearest 
monitoring 
stations from 
several sites 
(short-term 
exposure) 
CRP, blood 
cell counts, 
and whole-
blood 
viscosity 
PM2.5 Positive association for CRP 
and PM2.5 (A 100 µg/m3 was 
associated with a 0.81 mg/dL 
increase in CRP. ) 
Temperature and relative humidity No 
Peters et 
al. (2001) 
631 healthy men Based on one 
fix air 
monitoring  
station (short-
term exposure) 
Hs-CRP TSP, CO, 
and SO2 
The odds ratio for observing a 
CRP concentration above 90th 
percentile (above 5.7 mg/l) for 
a 5 days mean of TSP (increase 
of 26 µg/m3)  and SO2 were 
1.46 (95%CI=1.17-1.82) and 
1.24 (95%CI=1.03-1.49), 
respectively. 
Age, BMI, smoking, HDL, temperature, 
and humidity 
Yes 
Seaton et 
al. (1999) 
112 healthy 
people 
Both personal 
exposure 
estimate based 
on air 
monitoring data 
with diary, and 
fix air 
monitoring 
station 
Haemoglobin, 
packed cell 
volume, red 
and white cell 
counts, 
platelets, IL-6, 
Fibrinogen, 
Factor VII, 
and CRP 
PM10 The mean change of CRP for a 
3 days mean of PM10 (per 100 
µg/m3 increase) was 147% 
(95%CI=20%-477%). 
City, season, temperature, and repeated 
individual measurements 
No 
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Table 4 (continued)  
Zeka et 
al. (2006) 
710 healthy men Two fix 
monitoring 
stations 
CRP, 
fibrinogen, 
and sediment 
rate 
PN, BC, 
PM2.5, and 
SO42- 
Positive association for CRP 
and particulate air pollution. A 
7.29% (-1.63-16.21) increase of 
CRP was associated with one 
SD increase of 48 hours PN. A 
4.36% (95%CI=-3.25 to 11.96) 
increase of CRP was associated 
with one SD increase of 4 
weeks PM2.5.  
Age, BMI, season, temperature, humidity, 
and barometric pressure 
Yes 
WBC: white blood cell; hs-CRP: high-sensitivity C-reactive protein; FeNO : fractional exhaled nitric oxide; IL-8: interleukin-8; TNF-α : tumor necrosis factor-α ; sTNF-RII: 
TNF-α soluble receptor-II;  IL-6: interleukin-6;  IL-6sR: IL-6 soluble receptor; fibrin D-dimer;  sP-selectin: soluble platelet selectin; sVCAM-1: soluble vascular cell adhesion 
molecule-1; sICAM-1: intracellular adhesion molecule-1;  MPO: myeloperoxidase; SAA: serum amyloid A; vWF: von Willebrand factor antigen; ICAM-1: intercellular 
adhesion molecule 1; NK: Natural Killer 
 
PM10: particles diameter less than 10 µm; SO2: sulfur dioxide; NO2: nitrogen dioxide; CO: carbon monoxide; O3: ozone; PN: total particle number; EC: fine PM elemental 
carbon; OC: organic carbon; SOA: estimated secondary organic aerosol; OCpri: primary OC from total OC; OCsec: secondary OC from total OC; BC: black carbon; UFPs: 
ultrafine particles (number concentration of particles with a size range of 0.01 to 0.1 _m in diameter); AP: accumulation mode particles (particles with a size range of 0.1 to 1.0 
_m); TSP: total suspected particulates 
 
a also adjusted for medications including aspirin, beta blockers, calcium channel blockers, angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, statins, 
fibrates, oral hypoglycemics or insulin, and oral contraceptives or hormonal replacement therapy for women, cardiovascular risk factors including current and past smoking status, 
and family history of coronary heart disease or personal history of proven atherothrombotic event 
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Table 5. CRP during pregnancy 
Author Study Population Period/Time of CRP 
measurement 
Results Adjusted Variables Including 
Current 
Smoking 
Cicarelli et al. 
(2005) 
24 healthy pregnant 
women (full term), 12 
women undergoing 
vaginal delivery 
(VD), and 12 women 
undergoing Cesarean 
section (CD) 
 Admission 
 Delivery 
 24 hours after 
delivery 
 60 hours after 
delivery 
 A difference of CRP between VD and 
CD (p=0.01) were found after 24 and 60 
hours. 
 The maximum of CRP was observed at 
24 hours postpartum (5.8±3.6 for VD; 
11±5.3 for CD). 
 CRP was significantly higher in 
maternal serum than in newborn’s 
(p<0.001). 
NA NA 
Fialova et al. 
(2006) 
86 pregnant women in 
the 1st trimester; 102 
pregnant women in 
the 2nd trimester; 26 
non-pregnant women 
 First trimester 
 Second trimester 
 Maternal CRP levels of pregnant 
women gradually increased during the 
1st and 2nd trimesters (p<0.05). 
 Maternal CRP levels were higher in 
pregnant women than in non-pregnant 
women (p<0.05). 
NA NA 
Hackney et al. 
(2008) 
190 mother-baby 
pairs 
 Maternal CRP 
genotype in the 
first trimester 
 Fetal CRP 
genotype 
 Maternal plasma 
CRP in the first 
trimester 
 There was no significant relationship 
between maternal first trimester plasma 
CRP concentration and maternal or fetal 
CRP genotype.  
Clinical variables include: 
BMI, smoking, race, parity 
and age  
Yes (55% 
tobacco use) 
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Table 5 (continued)  
Larsson et al. 
(2008) 
52 healthy women  7-17 weeks 
gestation 
 17-24 weeks 
gestation 
 24-28 weeks 
gestation 
 28-31 weeks 
gestation 
 31-34 weeks 
gestation 
 34-38 weeks 
gestation 
 Pre-delivery 
 The lower (2.5 percentile) and upper 
limits (97.5 percentile) for CRP 
between 7-17 weeks were 0.32-11.91 
(mg/L). 
 CRPs between 17-24 weeks were 0.40-
14.02. 
 CRPs between 24-28 weeks were 0.43-
20.28. 
 CRPs between 28-31 weeks were 0.43-
36.98. 
 CRPs between 31-34 weeks were 0.33-
11.92. 
 CRPs between 34-38 weeks were 0.64-
28.26. 
 Prepartum CRPs were 0.38-24.75. 
 Postpartum CPRs were 0.23-7.60. 
NA Yes 
(including 
two smokers) 
Picklesimer et 
al. (2008) 
775 pregnant women 
 
<26 weeks of 
gestation (median=14 
weeks) 
 Black women had higher median CRP 
concentrations than white women (7.68 
vs. 2.59 mg/L; P<0.001). 
Smoking and maternal weight Yes (17% 
smoking 
during 
pregnancy) 
Sacks et al. 
(2004) 
40 pregnant women; 
95 non-pregnant 
women 
4 weeks gestation  A mild systemic maternal inflammatory 
response was found in 4 weeks 
gestation. 
NA Yes  
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Table 6. CRP and preterm delivery 
Author Study Population Period/Time 
of CRP 
measurement 
Study 
Design 
Results Adjusted Variables Including 
Current 
Smoking 
Boggess et al. 
(2005) 
44 cases 
(spontaneous 
abortion or fetal loss 
< 21 weeks 
gestation); 88 
controls (full-term) 
< 21 weeks 
gestation 
Nested 
case-
control 
 Pregnancy is not associated with 
increase CRP concentrations. 
 Women with CRP levels greater than 
75% percentile had a decrease risk of 
pregnancy loss (OR=0.20, 95%CI=0.06-
0.65) 
Maternal smoking, 
gestational age at blood 
draw, and insurance status 
Yes  
Catov et al. 
(2007) 
109 cases (<34 and 
34-37 gestational 
weeks) and 228 
controls 
< 21 weeks 
gestation 
Nested 
case-
control 
 A positive linear relationship between 
CRP and risk of sPTB at 34-37 weeks. 
 Early pregnancy inflammation (CRP ≥ 8 
µg/ml) increased risk of sPTB by 2.6- to 
2.8-fold. 
Race, BMI, 
periconceptional 
multivitamin use, and 
gestational age at 
sampling 
Yes  
Lohsoonthorn 
et al. (2007) 
146 cases (<34 and 
34-36 gestational 
weeks) and 1623 
controls 
13 weeks of 
gestation 
Nested 
case-
control 
 The odds ratio of preterm delivery for 
highest quartile (≥7.5 vs. <2.0 mg/L) of 
CRP was 2.04 (95%CI=1.13-3.69). 
Maternal age, race, parity, 
pregnancy BMI, and 
gestational age at blood 
collection 
Yes  
Pitiphat et al. 
(2005) 
117 cases (delivered 
preterm, <37 weeks’ 
gestation); 117 
controls 
5.3-19.3 
weeks’ 
gestation 
Nested 
case-
control 
 The odds ratio of preterm delivery for a 
CRP level of at least 8 mg/L (vs. <8 
mg/L) was 2.55 (95%CI=1.05-6.20). 
 The odds ratio of preterm delivery for a 
CRP level of at least 12 mg/L (vs. <12 
mg/L) was 3.19 (95%CI=0.98-10.32). 
 
Gestational age at blood 
collection, gravidity, 
pregnancy BMI, 
genitourinary infection, 
maternal employment, 
annual household income, 
physical activity, alcohol 
consumption during the 
first trimester 
Yes (cases 
and 
controls 
were 
matched on 
age, race, 
and 
smoking 
status) 
Ghezzi et al. 
(2002) 
280 term delivery; 
10 delivery <34 
weeks; 16 delivery 
between 34 and 37 
weeks 
15-18 weeks 
gestation 
Cohort 
study 
 Women with  preterm delivery at <34 
weeks or <37 weeks had a higher median 
of amniotic fluid CRP concentrations 
than women with term delivery. 
 Amniotic fluid CRP and maternal blood 
CRP concentrations were not correlated. 
 Maternal blood CRP concentrations were 
not associated with preterm delivery.  
NA NA 
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2.0  SPECIFIC AIMS 
The specific aims and related hypotheses are: 
Specific Aim 1: Evaluate the associations between ambient air pollution (including CO, 
NO2, SO2, O3, PM2.5 and PM10) and inflammation by measuring the CRP concentrations, during 
early pregnancy (gestational weeks before 22 complete weeks). We hypothesize that maternal 
exposure to short term (up to 1 week before blood draw) and long term (1 month before blood 
draw) ambient air pollutants in the early period of pregnancy is associated with inflammation.  
Specific Aim 2: Evaluate the associations between smoking and inflammation and its 
relationship with preterm birth (gestational weeks <37). We hypothesize that maternal exposure 
to cigarette smoke during pregnancy is associated with inflammation, as well as increased CRP 
concentrations. 
Specific Aim 3: Evaluate the associations between ambient air pollution and blood 
pressure changes. We hypothesize that maternal exposure to ambient air pollution during early 
pregnancy is associated with increase mean systolic and diastolic blood pressure from early to 
later pregnancy.  
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3.0  PARTICULATE AIR POLLUTION EXPOSURE AND C-REACTIVE PROTEIN 
DURING EARLY PREGNANCY 
3.1 ABSTRACT 
BACKGROUND: While it is not well understood how air pollution leads to adverse pregnancy 
outcomes, it has been reported that high concentrations of C-reactive protein (CRP), a biomarker 
of systemic inflammation, increase the risk of preterm delivery. Here, we examine whether air 
pollution influences serum concentrations of CRP in early pregnancy in Allegheny County, PA. 
METHODS: In 1,696 women, we measured CRP concentrations in blood collected 
before the 22nd week of gestation from 1997-2001. We estimated levels of particles of less than 
10 µm (PM10) and less than 2.5 µm diameter (PM2.5), carbon monoxide (CO), nitrogen dioxide 
(NO2), sulfur dioxide (SO2), and ozone at the maternal ZIP code using Kriging interpolation for 
ambient station measures. Employing logistic regression we evaluated associations between air 
pollution and high CRP (≥ 8 ng/ml) concentrations. 
RESULTS: For non-smokers, we observed odds ratios of 1.41 (95% CI=0.99 – 2.00) and 
1.47 (95% CI=1.05 – 2.06) for high CRP concentrations per 9.2 and 4.6 µg/m3 increase in PM10 
and PM2.5 respectively averaged over 28 days prior to the blood sample; and an odds ratio of 1.49 
(95% CI=0.75 – 2.96) per 7.9 ppb increase in ozone during summer. We saw no associations in 
smokers or for other air pollutants and no evidence for effect measure modification by obesity. 
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CONCLUSIONS: PM10, PM2.5, and ozone exposures increase the odds of high CRP in 
early pregnancy suggesting that these air pollutants contribute to inflammation; thereby possibly 
affecting pregnancy outcomes adversely. 
3.2 BACKGROUND 
Numerous studies have linked ambient air pollution to adverse pregnancy outcomes, such as 
preterm birth, low birth weight (LBW), small for gestational age (SGA, a marker of intrauterine 
growth retardation (IUGR)), and a few investigated preeclampsia, perinatal mortality and cardiac 
birth defects. 26,28,29,89-92 Positive associations have been described most consistently for 
increased preterm birth and particulate matter exposures especially for exposures during the first 
and third trimester of pregnancy. 93 Some studies relying on measures of traffic density 
suggested that motor vehicle exhaust may be an important source for particulates. 94,95 The 
biologic mechanisms explaining air pollution effects on pregnancy outcomes, however, are not 
well understood.  
Inflammation is one pathway believed to be involved in particulate-induced adverse 
health outcomes including cardiovascular diseases, 96,97 and has also been hypothesized to 
influence birth outcomes. 52 Animal studies provide strong evidence that particulate exposure can 
cause localized inflammation. Both particles of less than 10 µm diameter (PM10), and less than 
2.5 µm diameter (PM2.5) elicit pulmonary inflammation in rats. 97,98 Similarly, exposure to diesel 
exhaust particles (DEP) and ultrafine carbon particles have been reported to induce an 
inflammatory reaction in the lung of mice. 99 Growing epidemiologic evidence suggests that 
exposure to air pollution, especially particulates, is associated with not only pulmonary 
34 
inflammatory and immune responses but also with systemic inflammation measured by increased 
concentrations of inflammatory markers, such as interleukin-6 (IL-6), tumor necrosis factor-α 
(TNF-α), C-reactive protein (CRP), fibrinogen, and white cell counts. 64,65,67-69 C-reactive protein 
is a sensitive marker of inflammation and infection. 71 Previous studies indicated positive 
associations for CRP and air pollution in different populations such as healthy men, the elderly 
or people with coronary heart disease. 64,65,68,69,100 
Yet, to our knowledge no studies have evaluated whether air pollution exposure increases 
the systemic inflammatory response in pregnant women, of interest because the special state of 
immune response during pregnancy allows the mother to tolerate the semi-allogeneic foetus. 101 
Particulate exposures during pregnancy have been hypothesized to induce acute placental 
inflammation. Alternatively systemic inflammatory responses may lead to alterations in maternal 
immunity, and in turn increase risk of adverse birth outcomes. 52 Here, we examine this 
hypothesis in 1,696 women enrolled in the Prenatal Exposures and Preeclampsia Prevention 
(PEPP) study, a cohort in which we previously demonstrated that inflammation (measured by 
CRP) during early pregnancy was associated with increased risk of preterm delivery. 81 The aim 
of our current study was to determine whether particulate air pollution (including PM10 and 
PM2.5) exposure contributes to increased C-reactive protein (CRP) concentrations above a 
threshold of 8 ng/ml during early pregnancy, at which concentration our previous results showed 
a strong excess risk of spontaneous preterm delivery at 34-<37 weeks (OR=2.9; 95% CI=1.1 – 
7.2). 
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3.3 MATERIALS AND METHODS 
3.3.1 Study Population 
The study population was drawn from the Prenatal Exposures and Preeclampsia Prevention study 
(PEPP), which enrolled 2,211 women from clinics and private practices between 1997 and 2001. 
Briefly, this prospective study recruited healthy women, ages 14-44 and at less than sixteen 
weeks gestation and followed them to delivery. A comprehensive questionnaire was 
administered at baseline and postpartum. The information obtained in the baseline questionnaire 
included maternal demographic characteristics, socioeconomic status, active and passive 
cigarette smoking, consumption of alcohol, other lifestyle factors and medical history. We also 
obtained maternal residential ZIP code information at delivery from the hospital record. We 
excluded women with pre-existing medical conditions (n=37) including chronic hypertension, 
chronic diabetes, and HIV to avoid large variations in CRP levels due to these conditions. Since 
we were interested in inflammation in the first half of pregnancy, we also excluded women 
without a blood sample taken before 22 weeks of gestation (n=145). Additionally, since we 
limited our analysis to singleton births and first-time participants in the PEPP study with a 
maternal residence ZIP code in Allegheny County, PA, a total of 1,696 women were included in 
this study. 
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3.3.2 Biomarker Assessment 
Maternal nonfasting blood samples were stored and frozen at -80 0C. We measured C-reactive 
protein (CRP) concentrations with a high-sensitivity enzyme-linked immunosorbent assay 
(ELISA) on the SpectraMax Me analyzer (Molecular Devices, USA), as described elsewhere. 102 
The detection limit of the CRP assay was 0.03 ng/ml with an intra-assay variability of 7 percent. 
3.3.3 Exposure Assessment 
We obtained ambient air pollution data including the concentrations of carbon monoxide (CO), 
nitrogen dioxide (NO2), sulfur dioxide (SO2), ozone (O3), PM10, and PM2.5 for Allegheny County 
and its neighboring counties (within 50 km of the Allegheny County boundary), from the 
Allegheny County Health Department (ACHD) and the Air Quality System (AQS) 
(http://www.epa.gov/ttn/airs/airsaqs/detaildata/downloadaqsdata.htm) of the Environmental 
Protection Agency (EPA) for the years 1996 to 2001. From 1999 to 2001, PM2.5 data were 
collected at 23 monitoring stations including 13 monitoring stations in Allegheny County (AC) 
and 10 monitoring stations in its neighboring counties. PM10 measurements were available from 
40 stations (18 monitoring stations in AC), SO2 from 32 stations (7 monitoring stations in AC), 
and O3 from 15 stations (3 monitoring stations in AC), while only 11 stations measured NO2 and 
CO during the study period (3 and 2 monitoring stations respectively in AC). For each station, 
the data include one-hour concentrations for CO, NO2, O3, and SO2; and 24-hour concentrations 
(some collected every day and others collected every 3rd or 6th day) for PM2.5 and PM10. 
Meteorologic variables including hourly temperature and daily relative humidity for the 
37 
Pittsburgh International Airport, Pittsburgh, PA monitoring station were obtained from the 
National Climate Data Center (http://www.ncdc.noaa.gov/oa/ncdc.html).  
We employed the space-time ordinary Kriging (STOK) interpolation method to estimate 
daily air pollution concentrations at the ZIP code level by averaging the estimated concentration 
of pollution at each centroid of the grid (size of 13.4 m2) within each ZIP code. Spatial and 
temporal variograms were fitted into a spherical semivariogram model separately based on 
temporally detrended residuals. In addition, we combined the spatial and temporal variograms to 
a space-time variogram by fitting a general product-sum model. 103 This modification of space-
time ordinary kriging has been shown to increase mean precision compared to ordinary kriging. 
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3.3.4 Statistical Analysis 
We used logistic regression analyses to evaluate the associations between air pollution and C-
reactive protein during early pregnancy. We dichotomized C-reactive protein concentrations at 8 
ng/ml, a threshold we previously found associated with increased risk of preterm birth. 11,81 We 
also evaluated C-reactive protein as a continuous measure in linear regression models after log 
transformation necessary to normalize the CRP distribution. We present our results from these 
models as percentage changes. For all regression models, we used the robust cluster variance 
estimator to account for clustering of maternal residences in ZIP codes. For each air pollutant we 
employed continuous (per interquartile range, IQR) pollutant measures on the same day the 
blood was drawn (lag 0) and also up to 7 days prior to the blood draw (lag 1-lag 7) based on 
previous reports suggesting that systemic inflammation may increase 7 days preceding a blood 
draw. 63,64,100 In addition, we also calculated mean pollutant concentrations for three additional 
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periods prior to the blood draw (i.e. 8-day averages (Day 0-7), 22-day averages (Day 0-21), and 
29-day averages (Day 0-28 before blood collection)) to allow evaluating chronic, longer term, 
and cumulative exposure effects.  
In all models, we controlled for gestational week in which the sample was collected 
(weeks), maternal body mass index (BMI) at enrollment/time of blood draw (kg/m2), maternal 
age (years), maternal race (White, African-American), maternal education (less than high school, 
high school, complete high school but did not complete college, complete college or greater), 
parity (first birth, second or subsequent birth), maternal cigarette exposure during early 
pregnancy (active smoker, non-active smoker but exposed to cigarette smoke at home or indoors 
elsewhere, non-active and non-passive smoker), household income (< 10,000, 10 - < 20,000, 20 - 
< 50,000, 50,000 or more), season of sample collection (spring, summer, fall, winter), and year 
entering the study (for PM10 and other pollutants spanning: 1997-2001; for PM2.5: 1999-2001). 
We also evaluated other potential confounders including marital status, alcohol intake during 
pregnancy, multivitamin or prenatal vitamin use, aspirin use within a year prior to pregnancy, 
employment, public assistance, daily mean temperature and relative humidity. Since these factors 
did not change the estimates for pollutants by more than 10 percent they were not included in the 
models we present here. 105 
Previous studies suggested that obesity and smoking status may modify the influence that 
air pollution has on inflammation. 65,100,106,107 Thus, we also conducted stratified analyses for 
obesity defined as BMI ≥ 30 kg/m2 and analyses for non-smokers only. In addition, sensitivity 
analyses were performed such that we only included non-smokers without environmental 
tobacco smoke exposure (ETS in non-active smokers reporting exposure to cigarette smoke at 
home or indoors elsewhere). Only one monitoring station measured ozone between October and 
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March in the study period; thus, the analysis for ozone was restricted to the summer months 
(April-September) when data were available for more stations.  
3.4 RESULTS 
Blood samples were collected at a mean of 10.2 (std=4.0) gestational weeks. The mean BMI in 
early pregnancy (at baseline) was 26.5 kg/m2 (std=6.7). In univariate and adjusted models, the 
crude odds (ORs) for elevated C-reactive protein concentrations (CRP ≥ 8 ng/ml) were higher in 
women for whom samples were collected later in gestation, who had higher BMI, were older, or 
of African-American race (Table 7), but not in women actively smoking or passively exposed to 
cigarette smoke during early pregnancy. 
Table 8 summarizes means and correlations for mean pollutant concentrations 0 to 7 days 
preceding the blood collection; correlations were very similar for longer averaging periods, but 
means were slightly lower. Average 8-day PM10 concentrations were highly correlated with 
PM2.5 (r = 0.9) and moderately with O3 (r = 0.5), but very weakly correlated with CO, SO2, and 
NO2. Similarly, PM2.5 was moderately correlated with O3 (r = 0.5) but only weakly correlated 
with CO, SO2, and NO2. 
Figure 1 and 2 represent the geographic distribution of study participants by race and ZIP 
code. Most of the African-American women lived in the inner city area while the majority of the 
White race participants lived in relatively urban areas. Figure 3 and 4 show the distribution of 
PM10 and PM2.5 respectively by ZIP code. The mean PM10 exposure concentrations (8-day 
averages) for White race is slightly higher than the exposure concentrations for African-
American (White: 25.9 µg/m3, SD=8.3; African-American: 26.2 µg/m3, SD=8.2). Similarly, we 
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also observed that African-American had higher 8-day mean exposure concentrations of PM2.5 
than White race women (African-American: 16.8 µg/m3, SD=5.3; White: 16.0 µg/m3, SD=5.2).   
3.4.1 Ambient air pollution and C-reactive protein 
Longer averaging periods, i.e., 0-21, and 0-28 day averages for PM10 increased the odds of 
having a CRP concentration above 8 ng/ml (Table 9). For an IQR increase in PM10 the odds 
ratios (ORs) of a CRP above 8 ng/ml were 1.23 (95% CI=0.97 – 1.57; 22-day average) and 1.18 
(95% CI=0.91 – 1.53; 29-day average) in adjusted single-pollutant models for the entire 
population. PM2.5 exposures also increased the ORs for high CRP concentrations when using 
longer averaging periods; i.e. the ORs were 1.32 (95% CI=1.05 – 1.67; 22-day average) and 1.26 
(95% CI=0.97 – 1.63; 29-day average) per IQR increase in adjusted single-pollutant models 
(Table 9). When we restricted our analyses to non-smokers only, effect estimates were generally 
larger for both PM10 and PM2.5. Per IQR increase in PM10 exposure the ORs for elevated CRP 
concentrations were 1.47 (95% CI=1.06 – 2.02; 22-day average) and 1.41 (95% CI=0.99 – 2.00; 
29-day average) in adjusted single-pollutant models for non-smokers, and per IQR increase in 
PM2.5 exposure they were 1.55 (95% CI=1.15 – 2.11; 22-day average) and 1.47 (95% CI=1.05 – 
2.06; 29-day average) (Table 9).  
Generally, effect estimates for both PM10 and PM2.5 were larger in size between lag days 
2 and 5. For non-smokers, a per IQR increase in PM10 exposure was associated with increased 
CRP during lag days 4 and 5, whereas PM2.5 exposure was associated with increased CRP during 
lag days 1, 2, 4, and 5. However, none of these estimates achieved formal statistical significance. 
When we examined associations based on percentage change of log-transformed CRP in linear 
regression single-pollutant models 6-17% increases in CRP per IQR increase in PM10 or PM2.5 
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were suggested for smokers but none of these results were formally statistically significant 
(Figure 5). For non-smokers, only a small 2% increase in CRP per IQR increase in PM2.5 during 
a 22-day average period was suggested and 3-5% increases in CRP for an IQR increase in PM10 
for longer time periods, i.e., 0-21, and 0-28 day averages. When we examined interactions 
between BMI and particulates, the 95% confidence intervals of the estimates included one (data 
not shown). No evidence of effect measure modification was observed by obesity; i.e., the effect 
estimates for particulates on CRP were similar in women with a BMI above 30 kg/m2 and below 
30 kg/m2 in early pregnancy. 
Positive associations were also observed between O3 and CRP for all longer averaging 
periods (Table 9). Generally, the estimates for particulates (PM10 and PM2.5) and O3 air pollution 
were slightly larger in size for non-smokers who in addition were not exposed to ETS. However, 
the exclusion of those with ETS exposure from the non-smoking group greatly reduced the 
sample size and precision of our estimates. For CO, SO2 and NO2 associations were null for both 
the entire population and non-smokers only (e.g., per IQR increase in CO 29-day average in 
adjusted single-pollutant models ORs=1.05, 95% CI=0.86 – 1.30 entire population; ORs=0.95, 
95% CI=0.71 – 1.27 non-smokers only). 
3.5 DISCUSSION 
We observed positive associations between particulate (both PM2.5 and PM10) and O3 air 
pollution and elevated concentrations of a systemic inflammatory biomarker, CRP, in non-
smoking women during early pregnancy. These findings support the hypothesis that these 
exposures during pregnancy induce an inflammatory response which may result in an increased 
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risk for adverse birth outcomes especially preterm birth which we have previously shown to be 
associated with these higher CRP concentrations (above 8 ng/ml). 81  
 To date, few studies have examined associations between air pollution and inflammation 
in pregnant women, even though this has been studied extensively in other susceptible 
populations such as the elderly and children. 68,69,100,107 We found primarily medium term 
particulate exposures (up to 28 days prior to blood collection) to be associated with CRP 
concentrations above 8 ng/ml which previous studies had linked to an increase in preterm birth 
risk 11,81. However, due to insufficient sample size (99 preterm births among 1,129 non-smoking 
women), we did not have sufficient sample size to examine whether inflammation – specifically 
CRP plays a mediating role for the associations between air pollutants and adverse birth 
outcomes. Nevertheless, our findings that particulates and O3 increase the odds of having 
elevated CRP concentrations in early pregnancy provide some insight into pathways through 
which air pollution may influence birth outcomes. 
 While the gaseous combustion related air pollutants CO, NO2, and SO2 have also been 
associated with adverse birth outcomes before, 26,89,93 we did not find associations with high C-
reactive protein in our study. In Allegheny County, the major sources of CO, NO2, and particles 
are motor vehicles and industrial plants. With the same sources of origin, we would expect 
particles, CO, and NO2 to be positively correlated. However, only very weak correlations 
between our particle, CO, and NO2 measures were observed. This is most likely due to a very 
small number of monitoring stations that measured CO and NO2 (2 and 3 monitoring stations 
respectively) in all of Allegheny County. Since CO is highly spatially heterogeneous, i.e., its 
distributional peaks basically follow roadways, thus, data from only two monitoring stations will 
not represent these sources and their spatial distribution well enough. Our findings that 
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particulates were associated with inflammation indicate that particles from sources such as motor 
vehicles or industrial plants present important adverse exposures for pregnant women and that 
our spatial model based on a larger number of particulate monitoring stations likely captured 
particulate exposures from these sources better than the monitoring for gaseous combustion 
products does. However, unlike other gaseous pollutants ozone is spatially more homogenous 
and we expect the three monitoring stations combined with our spatial interpolation model to 
have represented ozone exposures appropriately.   
Previous studies investigated various lag times for air pollution exposures and 
inflammatory markers and generally assumed effects to be acute and to occur within 7 days prior 
to sample collection. Only a few studies examined longer time periods (i.e., months or years). 
30,65,106 Our results for particulate exposures are generally consistent with other studies. Zeka et 
al. (2006) reported that a 7.95 µg/m3 increase in a 4-week average PM2.5 resulted in a 4.4% (95% 
CI=-3.3 to 12.0%) increase in CRP among 710 healthy men. Similarly, we observed that a 5.0 
µg/m3 increase in 29-day average PM2.5 prior to blood collection was associated with a 3.8% 
increase in C-reactive protein (95% CI=-6.7 to 15.6%) for the entire population. Rückerl et al. 
(2006) studied the influence of air pollution on markers of inflammation and coagulation among 
57 men with coronary heart disease. For a CRP concentration greater than 8.5 mg/l, they reported 
an odds ratio of 1.4 (95% CI=0.9 – 2.3) for an IQR (12.2 µg/m3) increase in 5-day average PM2.5, 
and an odds ratio of 2.0 (95% CI=1.2 – 3.7) for an IQR (12.8 µg/m3) increase in 5-day average 
PM10. In this repeated measure panel study of males the estimated effect for PM2.5 was in the 
range of our finding in non-smokers (OR= 1.17; 95% CI=0.90 – 1.52 for CRP ≥8 ng/ml per 5.8 
µg/m3 increase in PM2.5 8-day average); our estimated effect size for PM10 however was much 
smaller and did not suggest an association for this short averaging period. 
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 We also found consistent positive associations between O3 in summer (April to 
September) and high CRP levels. Exposure to ozone has been associated with airway as well as 
systemic inflammation. 67,108 O3 has a strong oxidative potential and is likely to generate reactive 
oxygen and nitrogen species and increase inflammatory reactions. 109 Ozone exposures are 
associated with increased levels of interleukin-8 (IL-8) and interleukin-6 (IL-6) in asthmatic 
children and nonsmoking adults. 67,109 Recently, a longitudinal study110  following 40 healthy 
individuals reported a 5.9% (95% CI=-6.8 to 18.7%) increase in CRP for a 42 µg/m3 increase on 
lag day4 O3 exposure, and this was similar to our finding (3.6% increase; 95% CI=-8.5 to 17.3 % 
on lag day4 per 14.0 ppb) in the summer months for non-smokers.  
We found no indication that BMI modifies the associations between particulates and C-
reactive protein in pregnant women; i.e. the sizes of our effect measures were similar for normal 
weight and obese women. Our results are contrary to previous findings that linked air pollution 
to markers of inflammation in elderly and healthy male populations and reported that 
associations for short-term air pollution and inflammation markers (i.e., CRP and IL-6) were 
more pronounced in obese individuals and those with diabetes or hypertension. 65,100 These 
differences may be due to the fact that we excluded pregnant women with pre-existing health 
conditions such as chronic hypertension and chronic diabetes and that our BMI measure was 
inaccurate since in our study weight at baseline was measured as early as 3 and as late as 22 
weeks of gestation. However, very few women had their blood collected later than 20 weeks of 
gestation when weight during pregnancy increases rapidly. Additionally, although we observed 
that African-American women exposed to higher PM10 and PM2.5 concentrations than White race 
participants, we did not find effect modifier by race. This may due to (1) the difference of 
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exposure concentrations is very small (less than 1 µg/m3) and (2) the available geographic 
information is in ZIP code level not individual.                 
Much evidence has accumulated that maternal exposure to air pollution is associated with 
adverse birth outcomes or pregnancy complications. CRP concentrations are generally higher in 
pregnant than non-pregnant women, 77 and placentally derived microparticles or soluble products 
from the placenta are suspected to drive systemic inflammation during normal pregnancy. 101 An 
increased inflammatory response during pregnancy is present in preeclampsia, small for 
gestational age (SGA), and preterm birth. 8,11,81,111 Two studies examined the associations 
between maternal plasma CRP concentrations in early pregnancy (before 21 weeks of gestation) 
and the risk of preterm delivery and reported 2.6- to 2.9-fold increases in risk of preterm delivery 
with early pregnancy inflammation (CRP ≥ 8 ng/ml). 11,81 Cord blood concentrations of 
inflammatory markers such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), 
thrombopoietin (TPO), and C-reactive protein were reported to be significantly higher in SGA 
infants compared with appropriate-for-gestational-age controls. 111 Thus, our findings provide 
some evidence that inflammation is one possible pathway through which air pollution may act to 
increase the risk of experiencing adverse birth outcomes such as SGA and preterm delivery.  
The primary strength of our study is that we were able to examine variables that may 
have confounded the associations we examined, including active and passive smoking, maternal 
nutrition (i.e., multivitamin or prenatal vitamin use), and BMI. Our BMI information was based 
on measurements in early pregnancy not on self-report. Our study also has several limitations. 
First, we did not have maternal infection information during the period when blood was 
collected. Since we were unable to control for acute infections, this may have confounded our 
short term results (0-7 lag days). However, some infections such as respiratory infection are 
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likely on the causal pathways between air pollution and CRP increases and it would be 
inappropriate to control for such an intermediate factors. Second, we relied on residential 
information at time of the birth of the infant rather than at the time we collected the blood 
samples, and we assumed that mothers did not move during pregnancy and that the estimates of 
residential air pollution were representative of the woman’s personal exposures all of which may 
have resulted in exposure measurement error. Since our study population was drawn from the 
longitudinal PEPP cohort, in which participants received their prenatal care and delivered in the 
same hospital, we believe that it is reasonable to assume that most women in our study either did 
not move or only moved within the same neighborhood (or ZIP code) during pregnancy as also 
suggested by Chen et al. (2010). 112 While we conducted a large number of statistical tests, the 
consistency and magnitude of our findings for particulates and O3 air pollution and high C-
reactive protein concentrations make it less likely that our results are due to chance only. 
Additionally, we dichotomized continuous CRP concentrations at a cut point of 8 ng/ml which 
may affect the statistical power and lose information. We are further exploring a new approach to 
calculate odds ratios for continuous CRP concentrations without dichotomizing it.   
3.6 CONCLUSIONS 
Our study suggests that particulate matter (PM10 and PM2.5) air pollution and ozone exposures 
during early pregnancy contribute to systemic inflammation as measured by CRP. Our findings 
provide some new evidence that effects of particulate air pollution on adverse birth outcomes 
may be mediated by systemic inflammation. 
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3.7 TABLES AND FIGURES 
Table 7. Demographic characteristics of study population by CRP concentration (N=1,696) 
 CRP < 8 ng/ml CRP ≥ 8 ng/ml Crude OR 
(95% CI) 
Adjusted ORa 
(95% CI)  Mean 
or no. 
SD or 
% 
Mean 
or no. 
SD or 
% 
Gestational weeks at sample 
collection (weeks) 10.0 3.9 11.6 4.2 1.10 (1.07 – 1.14) 1.13 (1.09 – 1.17) 
Maternal BMI at baseline 
(kg/m2) 25.4 5.9 32.5 7.8 1.14 (1.12 – 1.17) 1.15 (1.12 – 1.18) 
Maternal age (years) 24.6 5.8 26.4 6.1 1.05 (1.03 – 1.08) 1.07 (1.03 – 1.11) 
Maternal race/ethnicity       
  White 905 64 128 52 1 1 
  African American 509 36 118 48 1.64 (1.25 – 2.15) 1.31 (0.91 – 1.87) 
Maternal education       
  Less than high school 302 21 46 19 1.15 (0.72 – 1.83) 1.26 (0.62 – 2.55) 
  High school 544 37 107 43 1.48 (0.99 – 2.22) 1.46 (0.81 – 2.61) 
  Less than 4 years college 332 23 58 23 1.32 (0.84 – 2.05) 1.02 (0.57 – 1.84) 
  Above College/Bachelor 271 19 36 15 1 1 
Parity       
  First birth  913 63 110 45 1 1 
  Second or subsequent birth 536 37 137 55 2.12 (1.62 – 2.79) 0.99 (0.68 – 1.43) 
Maternal cigarette exposure 
during early pregnancy       
  Active (smokers)  480 33 73 30 0.72 (0.50 – 1.02) 0.88 (0.57 – 1. 37) 
  Passive (non-smokers) 610 43 97 40 0.75 (0.54 – 1.04) 0.93 (0.63 – 1.38) 
  None 348 24 74 30 1 1 
Household income (thousands)       
  Less than 10 360 25 74 30 1 1 
  10 to less than 20 287 20 55 22 0.93 (0.64 – 1.37) 1.02 (0.64 – 1.62) 
  20 to less than 50 289 20 52 21 0.88 (0.59 – 1.29) 1.06 (0.66 – 1.71) 
  50 or more  259 18 38 16 0.71 (0.47 – 1.09) 1.13 (0.61 – 2.11) 
  Unknown 254 17 28 11 0.54 (0.34 – 0.85) 0.67 (0.38 – 1.18) 
Year entering the study       
  1997 187 13 18 7 1 1 
  1998 272 19 34 14 1.30 (0.71 – 2.37) 1.21 (0.60 – 2.45) 
  1999 331 23 49 20 1.54 (0.87 – 2.72) 1.04 (0.53 – 2.04) 
  2000  396 27 92 37 2.41 (1.41 – 4.11) 1.63 (0.85 – 3.13) 
  2001 263 18 54 22 2.13 (1.21 – 3.75) 1.63 (0.82 – 3.24) 
Season of sample collected       
  Spring (March-May) 451 31 84 34 1 1 
  Summer (June-August) 367 25 61 25 0.89 (0.62 – 1.28) 0.73 (0.48 – 1.11) 
  Fall (September-November) 321 22 49 20 0.82 (0.56 – 1.20) 0.75 (0.48 – 1.19) 
  Winter (December-February) 310 22 53 21 0.92 (0.63 – 1.33) 0.96 (0.62 – 1.48) 
a Adjusted for all other covariates in the table 
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Table 8. The descriptive statistics of air pollution (0-7 day averages) 
   Percentile  Pearson Correlation 
 Mean ± SD 0th 25th 50th 75th 95th 100th  PM10 PM2.5 O3 CO SO2 NO2 
PM10 (µg/m3) 26.1 ± 8.3 10.7 19.9 24.4 31.2 42.2 58.7  1      
PM2.5 (µg/m3) 16.4 ± 5.3 7.1 12.8 15.2 18.7 26.2 40.8  0.9 1     
O3 a(ppb) 29.9 ± 7.1 4.4 25.6 30.3 34.3 41.6 51.4  0.5 0.5 1    
CO (ppm) 0.5 ± 0.2 0.0 0.3 0.5 0.6 0.9 1.4  0.1 0.0 -0.1 1   
SO2 (ppb) 8.4 ± 3.3 1.5 6.1 7.9 10.1 14.4 25.4  0.1 0.2 0.1 0.3 1  
NO2 (ppb) 18.8 ± 3.8 8.2 15.9 18.7 21.1 25.1 33.4  0.1 0.1 0.0 0.6 0.4 1 
a For summer season only (April to September) 
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Table 9. Associations between CRP (<8 vs ≥8 ng/ml), particulates and O3 air pollution per IQR increase by lag 
period for the entire population (N=1,696) and non-smokers (N=1,129) 
  Crude Adjusteda 
Pollutant/lag periods IQRs OR (95% CI) OR (95% CI) 
For the entire population    
  PM10 (µg/m3)  N=1,696 N=1,576 
      Day 0-7 11.3 1.02 (0.84 – 1.24) 1.05 (0.81 – 1.36) 
      Day 0-21   9.8 1.06 (0.88 – 1.28) 1.23 (0.97 – 1.57) 
      Day 0-28   9.2 1.03 (0.85 – 1.26) 1.18 (0.91 – 1.53) 
  PM2.5 (µg/m3)  N=1,189 N=1,084 
      Day 0-7   6.0 1.17 (1.00 – 1.38) 1.21 (1.02 – 1.43) 
      Day 0-21   5.2 1.19 (1.01 – 1.40) 1.32 (1.05 – 1.67) 
      Day 0-28   5.0 1.16 (0.96 – 1.41) 1.26 (0.97 – 1.63) 
  O3b (ppb)  N=909 N=833 
      Day 0-7   8.7 1.02 (0.83 – 1.24) 1.27 (0.87 – 1.86) 
      Day 0-21   8.2 0.96 (0.76 – 1.23) 1.26 (0.78 – 2.03) 
      Day 0-28   7.7 0.91 (0.72 – 1.15) 1.05 (0.65 – 1.71) 
For non-smokers    
  PM10 (µg/m3)  N=1,129 N=1,060 
      Day 0-7 11.0 0.98 (0.78 – 1.24) 1.05 (0.77 – 1.44) 
      Day 0-21   9.9 1.13 (0.88 – 1.45) 1.47 (1.06 – 2.02) 
      Day 0-28   9.2 1.10 (0.86 – 1.42) 1.41 (0.99 – 2.00) 
  PM2.5 (µg/m3)  N=786 N=726 
      Day 0-7   5.8 1.15 (0.93 – 1.43) 1.17 (0.90 – 1.52) 
      Day 0-21   5.2 1.29 (1.04 – 1.62) 1.55 (1.15 – 2.11) 
      Day 0-28   4.6 1.25 (0.98 – 1.60) 1.47 (1.05 – 2.06) 
  O3b (ppb)  N=579 N=539 
      Day 0-7   9.0 1.03 (0.75 – 1.40) 1.15 (0.69 – 1.89) 
      Day 0-21   8.3 1.06 (0.72 – 1.58) 1.60 (0.83 – 3.09) 
      Day 0-28   7.9 1.05 (0.72 – 1.55) 1.49 (0.75 – 2.96) 
a Adjusted for gestational week at sample collection, maternal BMI at enrolment, maternal age, race, education, 
parity, cigarette smoke exposure during early pregnancy, household income, season of sample collection (only 
adjusted in PM10 and PM2.5 models), and year of enrolment (for PM10 and O3: 1997 to 2001; for PM2.5: 1999 to 
2001); month of enrolment was also adjusted in O3 models 
b Restricted to participants enrolled in the study in the months of April -September only 
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Figure 1. Geographic distribution of African-American by ZIP code 
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Figure 2. Geographic distribution of White race by ZIP code 
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Figure 3. The distribution of PM10 by ZIP code 
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Figure 4. The distribution of PM2.5 by ZIP code 
  
54 
 
Figure 5. Percentage change for CRP with ambient PM2.5 and PM10 exposures (per IQR increase) in smokers and 
non-smokers. 
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4.0  DOES SYSTEMIC INFLAMMATORY RESPONSE, MEASURED BY C-
REACTIVE PROTEIN, MEDIATE THE LINK BETWEEN SMOKING AND PRETERM 
DELIVERY? 
4.1 ABSTRACT 
Maternal smoking during pregnancy is associated with several adverse pregnancy outcomes such 
as preterm delivery and intrauterine growth restriction but the underlying biological mechanism 
for this adverse effect is not well-understood. We hypothesized that systemic inflammation may 
play a role linking smoking and preterm delivery. We conducted a matched case-control study 
from the Prenatal Exposures and Preeclampsia Prevention study (PEPP) between 1997 and 2001 
in Pittsburgh, PA. Smoking status was assessed by serum cotinine concentration and C-reactive 
protein (CRP) was measured as a biomarker of inflammation. Mediation analyses were 
performed to test whether inflammation mediates the relationship between smoking and preterm 
delivery. We observed a null association between smoking and inflammation (odds ratio=0.95, 
95% CI=0.50 – 1.82) for cotinine concentrations above 100 ng/ml vs. below 5 ng/ml). We did 
not observe an association between elevated CRP concentrations (≥8 ng/ml) (odds ratio=1.30, 
95% CI=0.76 – 2.24) and the risk of preterm delivery in the adjusted model. After adjustment for 
race and body mass index, smoking (odds ratio=1.72, 95% CI=1.12 – 2.64 for cotinine 
concentrations above 100 ng/ml vs. below 5 ng/ml) during early pregnancy were associated with 
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preterm delivery. Our data suggest that systemic inflammation may not be the mediating link 
between smoking and preterm delivery. 
4.2 BACKGROUND 
Preterm birth is a major cause of morbidity among neonates and is an indicator for impaired 
organ development, which results in adverse health effects in childhood and adult life 113,114. 
Smoking is a recognized risk factor for preterm delivery and many studies have reported positive 
associations between maternal smoking during pregnancy and risk of preterm birth 115-118, with 
results from a meta-analysis reporting an odds ratio (OR) for having preterm delivery of 1.27 
(95% confidence interval (CI): 1.21 – 1.33) for mothers who smoked during pregnancy 
compared to those who did not 119.   
The mechanism to account for the increased risk of preterm delivery as a result of smoking 
remains unknown. Low grade inflammation, endothelial dysfunction, and carbon monoxide 
induce fetal hypoxia have been hypothesized to account for the role of smoking on pregnancy 
complications or fetal growth 117,120,121. Luppi et al. (2007) observed an increased frequency of 
CD3+ lymphocytes but a reduced expression of CD54 on monocytes and CD62L on granulocytes 
in smokers during early pregnancy122. Furthermore, Simhan et al. (2005) reported a dose-
response relationship between cervical anti-inflammatory cytokine concentrations, i.e., 
interleukin (IL)-4, 10, and 13, and number of cigarette smoked during pregnancy, and the 
increase in anti-inflammatory cytokine concentrations was observed without an increase in pro-
inflammatory cytokines including IL-1α, IL-1β, IL-6, IL-8, tumor necrosis factor-α (TNF-α), and 
monocyte chemotactic protein-1 (MCP-1).123. 
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Recently, a growing amount of literature has documented the association between 
systemic inflammatory biomarkers and preterm delivery with higher risk of preterm for women 
with elevated inflammatory biomarker concentration 11,80,81. However, few studies have 
systematically examined the association between smoking and systemic inflammation in relation 
to the risk of preterm birth for pregnant women. The objective of the current study was to 
examine whether inflammation, as indicated by the circulating concentration of serum CRP, 
mediates the link between smoking and preterm birth by measuring serum cotinine, and preterm 
delivery. CRP was selected because it has been widely used in the studies of smoking, preterm 
delivery, and systemic inflammation. We performed a mediational analysis recommended by 
Judd and Kenny 124. A series of models were evaluated to test the effects of inflammation as a 
mediator in the relation between smoking and preterm delivery, including (1) smoking and 
preterm delivery, (2) smoking and inflammation, (3) inflammation and preterm delivery, and (4) 
smoking, inflammation, and preterm delivery. We hypothesized that (1) higher serum cotinine 
concentration is associated with increased preterm delivery, (2) higher serum cotinine 
concentration also is associated with higher CRP concentrations, (3) elevated CRP concentration 
is associated with preterm delivery, and (4) the effect size of cotinine on preterm delivery is 
attenuated when we control for CRP concentrations. 
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4.3 MATERIALS AND METHODS 
4.3.1 Study Design and Study Population 
This is a matched case-control study of 167 cases and 498 controls who were enrolled in the 
PEPP study between 1997 and 2001. The PEPP study was a prospective longitudinal study with 
enrollment of 2,211 healthy women, ages 14-44, who had been pregnant for less than sixteen 
weeks and followed to delivery. In our study, we excluded women with pre-existing medical 
conditions (n=37) including chronic hypertension, chronic diabetes, and HIV, as these conditions 
are associated with preterm delivery risk. Since we were interested in inflammation in the first 
half of pregnancy, we also excluded women without a blood sample taken before 22 weeks of 
gestation (n=145), and limited our analysis to singleton births whose mothers reside in 
Allegheny County, PA. Of 1,696 eligible women, 167 delivered preterm, defined as delivery 
before 37 gestational weeks. For each woman who delivered before 37 weeks of gestation 
(cases), we randomly selected 3 women with normal term delivery (controls), defined as 
gestational weeks at delivery ≥ 37 and matched maternal age (±3 years) and gestational age (±2 
weeks) at baseline. Since only two matched controls were found for three cases, the total controls 
in our study were 498 women. Each participant in the PEPP study signed a consent form 
approved by the Institutional Review Board at the University of Pittsburgh. 
4.3.2 Biomarkers Assessment 
Maternal nonfasting blood samples were stored and frozen at -80 0C. We evaluated the first 
sample collected before 22 weeks of gestation. The mean gestational weeks at sample collection 
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was 11.5 (std=6.3) for cases and controls. Concentrations of CRP were measured with a high-
sensitivity enzyme-linked immunosorbent assay (ELISA) on the SpectraMax Me analyzer 
(Molecular Devices, USA), described elsewhere 102. The detection limit of the CRP assay was 
0.03 ng/ml, with an intra-assay variability of 7 percent. Concentrations of serum cotinine were 
measured with the Cotinine Direct ELISA kit on the SpectraMax Me analyzer (Molecular 
Devices, USA). The intra- and interassay variation was smaller than 10%.  
4.3.3 Covariates 
Women who participated in the PEPP study underwent a basic physical exam including height 
and weight and an in-person interview at their first prenatal visit. The covariates that were 
considered include: maternal body mass index (BMI) at enrollment/time of blood draw (kg/m2), 
maternal race (White, African-American), marital status (married, un-married), maternal 
education (less than high school, high school or greater), parity (first birth, second or subsequent 
birth), public assistance (yes/no), alcoholic drinks prior to the first prenatal visit (yes/no), and 
periconceptional multivitamin use (multivitamin use prior to the first prenatal visit).  
4.3.4 Statistical Analyses 
The study design was matched case-control for preterm delivery, but we also examined the 
continuous gestational weeks at delivery in relation to concentrations of cotinine and CRP. The 
residuals of cotinine concentrations and gestational weeks at delivery were not normally 
distributed; thus, we centered the gestational weeks at 43 and log transformed the centered 
gestational weeks, i.e., log(43-gestational weeks at delivery). Linear regression models were 
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used to examine the relationship between smoking and gestational weeks and to test the 
mediation of inflammation. Beta coefficients and 95% confidence intervals (95% CIs) of 
cotinine concentrations were reported to represent the association with gestational weeks after 
controlling for maternal age, race, gestational weeks at baseline, and BMI. 
Odds ratios (ORs) and 95% confidence intervals of preterm delivery associated with 
cotinine and CRP concentrations were estimated separately using conditional logistic regression. 
We classified cotinine concentrations into 3 groups: <5, 5-100, and greater than 100 ng/ml to 
represent non-smokers, light smokers, and heavy smokers, respectively 122,125. The residuals of 
cotinine concentrations and CRP concentrations were not normally distributed, so log 
transformation was used to examine the association between smoking and inflammation by 
utilizing linear regression at robust estimator. In addition to examining continuous CRP 
concentrations, we also categorized CRP concentrations as <8 and ≥8 ng/ml because studies have 
shown that elevated CRP concentration above 8 are associated with preterm delivery 11,81. A 
logistic regression model with a robust estimator was fit to examine the relationship between 
CRP (<8, ≥8 ng/ml) and cotinine concentrations after controlling for maternal age, race, 
gestational weeks at baseline and BMI. Conditional logistic regression models were fit to (1) 
examine the relationship between CRP and preterm delivery, (2) examine the relationship 
between smoking and preterm delivery, and (3) test CRP as a mediator in the relationship 
between smoking and preterm delivery. Covariates were included only if they changed the 
estimate more than 10 percent. Multivariable conditional logistic regression models were 
adjusted for maternal race, and BMI. All the analyses were conducted using StataSE10 (Stata 
Corp, College Station, TX). 
61 
4.4 RESULTS 
The mean gestational weeks at blood collection was 11.5 weeks (std=6.3) for cases and controls. 
The mean BMI in early pregnancy (at baseline) was 26.7 kg/m2 (std=7.0) for women who 
smoked (cotinine concentrations >100 ng/ml) and 26.8 kg/m2 (std=6.9) for non-smokers 
(cotinine concentrations <5 ng/ml). Women who were heavy smokers (cotinine concentration 
≥100ng/ml) were more likely to be un-married, have second or subsequent births, and drink 
alcohol, and less likely to report multivitamin use, and need public assistance (Table 10). 
4.4.1 Results based on gestational weeks 
In the adjusted linear regression model, cotinine concentrations showed a small but significant 
association with gestational weeks at delivery (beta coefficient=0.0005782, 95% CI=0.0000515 
– 0.001104). After untransforming the coefficient, we observed an approximately one week 
reduction of gestational weeks at delivery was associated with cotinine concentrations equal to 
400ng/ml compared to those with zero cotinine concentrations; and when cotinine concentrations 
were equal to 100 ng/ml, the gestational weeks at delivery was reduced 1 day. This relationship 
remained the same when CRP concentration was entered in the model.    
4.4.2 Results based on preterm delivery 
The median CRP concentration was 3.0 ng/ml for preterm group and 2.8 ng/ml for controls. 
There was no strong evidence that every 1 unit increase in CRP concentration was associated 
with preterm delivery (OR=0.95, 95% CI=0.78 – 1.16 in the adjusted model) (Table 11). 
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However, an elevated although non-significant relationship was observed when we used the cut 
point of 8 for CRP (adjusted OR=1.30, 95% CI=0.76 – 2.24). 
CRP concentrations were not correlated with cotinine concentrations (γ=-0.01, p=0.05). 
We observed null associations between cotinine concentrations (<5, 5-100, and above 100 ng/ml) 
and elevated CRP concentration (CRP below 8 ng/ml). The median cotinine concentrations were 
1.59 and 2.46 ng/ml for women with elevated CRP concentration (above 8 ng/ml) and CRP 
below 8 ng/ml, respectively. The OR of having elevated CRP concentration for women who had 
cotinine concentration between 5 and 100 was 0.94 (95% CI=0.44 – 2.01) and 0.95 (95% 
CI=0.50 – 1.82) for women who had CRP above 100 ng/ml in the adjusted models (Table 12). 
In the unadjusted model, cotinine concentrations above 100 ng/ml were significantly 
associated with preterm delivery (OR=1.66, 95% CI=1.10 – 2.48) compared to those with 
cotinine concentration below 5 ng/ml (Table 13). The relationship was similar when we 
controlled for maternal race and BMI (OR=1.72, 95% CI=1.12 – 2.64). When we evaluated 
whether CRP was a mediator of the effect of smoking on preterm delivery, we entered CRP 
concentration in the model with cotinine. No strong evidence of CRP as a mediator was noted. 
For example, the adjusted OR of preterm delivery for cotinine group in 5-100 and above 100 
ng/ml were 1.15 (95% CI=0.68 – 1.99) and 1.72 (95% CI=1.12 – 2.64), respectively, compared 
with 1.17 (95% CI=0.69 – 2.00) and 1.76 (95% CI=1.14 – 2.70), respectively when we adjusted 
for CRP (Table 13). 
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4.5 DISCUSSION 
We found that maternal smoking (measured by cotinine concentrations) and systemic 
inflammation (measured by CRP concentrations) during early pregnancy were independently 
associated with increased risk of preterm delivery. Our data, however, to not support the notion 
that systemic inflammatory responses mediates the link between smoking and preterm delivery. 
Our results linking elevated CRP concentrations to increased risk of preterm delivery are 
generally consistent with previous studies, although they reported stronger associations of 
preterm delivery for early pregnancy inflammation (CRP≥ 8 nm/ml) 11,81. Catov et al. (2007) 
examined the same cohort and reported a 2.6- to 2.8-fold increased risks of spontaneous preterm 
delivery for elevated CRP concentrations during early pregnancy while we only observed the 
odds ratio of 1.3 (95 % CI=0.76 – 2.24) for elevated CRP concentrations for preterm delivery. 
However, Catov et al. only included spontaneous preterm delivery while we also included 
women with indicated preterm birth, and we found that women with indicated preterm birth had 
higher CRP concentrations (median=3.3 ng/ml, range=24.3 ng/ml) than those with spontaneous 
preterm birth (median=2.9 ng/ml, range=18.1 ng/ml), which may have affected our results. In 
addition, different lot of ELISA used on measuring CRP concentrations may have also 
contributed to the different results.   
Studies of smoking and CRP concentrations in non-pregnant populations such as the 
elderly and adults have reported slightly higher CRP concentrations in smokers than never or 
non-smokers 126-131. However, in our current study, we observed that women who smoked had 
slightly lower CRP concentrations (median=2.4 ng/ml) than women who did not smoke (median 
CRP concentration=3.1 ng/ml). The inconsistent findings of CRP concentrations between 
smokers and non-smokers may be due to different data collection approaches and definitions of 
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smoking status. For example, most previous studies relied on self-report smoking information 
from interview or questionnaire and this approach may introduce information bias if women did 
not report their smoking status correctly. We, on the other hand, measured serum cotinine 
concentrations as a biomarker of smoking to define non-smokers (cotinine concentrations <5 
ng/ml), light (5-100 ng/ml) and heavy (>100 ng/ml) smokers, which may improve the 
classification of smoking status. Furthermore, different study populations may also contribute to 
this inconsistent finding. 
Pregnancy is a special state where dramatic changes in cardiovascular function and 
profound modifications of the maternal immune system occurr in order to adapt to the fetus. 
Luppi et al. (2007) examined the numbers of circulating leukocytes in a cohort of 198 pregnant 
women and they reported that smoking increased the frequency of CD3+ lymphocytes but 
decreased the expression of CD54 on monocytes and CD62L on granulocytes, and the decreased 
of adhesion molecules presentation on the surface of monocytes and granulocytes may be due to 
an inhibitory effect of smoking on the expression of adhesion molecules on leukocytes 132. In 
addition, Simhan et al. (2005) observed higher anti-inflammatory cytokines concentrations 
including interleukin-4, 10 and 13, in cervix among smokers compared to non-smokers, but no 
difference in proinflammatory cytokines concentrations was observed between smokers and non-
smokers. Therefore, smoking may affect the balance of pro- and anti-inflammatory responses 
that may reflect the risk of preterm birth. 
We found that mothers who smoked during early pregnancy had an increased risk of 
preterm delivery and a dose-response relationship was observed with higher cotinine 
concentrations. This was also reported by other studies. For example, Fantuzzi et al. (2007) in 
Italy showed a relationship between active smoking during pregnancy and preterm delivery 
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(adjusted OR= 1.53; 95% CI, 1.05-2.21). Although self-report smoking information during 
pregnancy was used by Fantuzzi et al., they also found a dose-response relationship for 1-10 
cigarettes smoking per day and risk of preterm delivery (OR=1.54, 95% CI=1.01-2.35); for >10 
cigarettes per day, the odds ratio of preterm birth (<37 weeks gestation) is 1.69 (95% CI=0.91-
3.13).  
The primary strength of our study is that smoking status was defined by serum cotinine 
concentrations not on the basis of self-report. Recently, a large population-based study estimated 
the percentage of nondisclosure of smoking status in US pregnant women and reported that 
among pregnant active smokers (defined by serum cotinine concentrations), 22.9% (95% 
CI=11.8 – 34.6) of them did not report smoking 133. Similarly, in our study, we found that among 
288 women with cotinine concentrations greater than 5 ng/ml, 72 (25%) of them did not report 
any cigarette smoked since pregnancy. Thus, our smoking information based on cotinine 
concentrations would reduce misclassification of smoking status due to pregnant women under- 
or over-reporting whether they smoked and how many cigarettes they smoked.  
Our study also has several limitations. First, although CRP is an acute-phase protein and 
is widely used as an inflammatory biomarker on studies of smoking and inflammation 126-131, we 
did not examine other pro-inflammatory biomarkers such as interleukin (IL)-6 (IL-6), IL-1β and 
tumor necrosis factor (TNF-α) to evaluate how other systemic inflammatory bio-markers also 
play a role in the relationship of smoking and preterm delivery. However, cytokines IL-6, IL-1β, 
and TNF-α have been reported to mediate CRP mRNA transcription and they have shown a 
moderate significant correlation with CRP 134,135. In addition, there was insufficient sample size 
to examine the relationship of smoking and inflammation on different periods of gestational 
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weeks at delivery among preterm births, such as gestational weeks <34, and 34-<37 weeks, or 
stratified the analyses on spontaneous or indicated preterm delivery status.                
Numerous studies have reported on the adverse effects of smoking during pregnancy and 
preterm delivery.  Additionally, researchers have also linked increased inflammatory response 
(CRP) with increased risk of preterm delivery.  However, there is little evidence linking all three 
in a systematic fashion.  The present study examined the relationship of smoking at baseline 
exam, CRP level and subsequent preterm delivery in a population of women in Allegheny 
County.  The results did not demonstrate a mediated effect of smoking and preterm delivery. 
Consideration of multiple inflammatory biomarkers as well repeated measures during pregnancy 
time periods are needed to clarify the role of systemic inflammation on the pathway of smoking 
and preterm delivery. 
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4.6 TABLES 
Table 10. Demographic characteristics of study participants by cotinine concentrations 
 Cotinine Concentrations (ng/ml) 
 <5 
n=377 
5 to <100 
n=110 
≥100 
n=178 
 N % N % N % 
Maternal race/ethnicity a       
  White 228 61.5   57 51.8 103 59.2 
  African American 143 38.5   53 48.2   71 40.8 
Maternal education       
  Less than high school   58 15.4   27 24.5   57 32.0 
  Above high school 319 84.6   83 75.5 121 68.0 
Marital status a       
  Un-married 179 47.6   69 62.7 110 61.8 
  Married 197 52.4   41 37.3   68 38.2 
Parity        
  First birth  244 64.7   76 69.1   90 50.6 
  Second or subsequent birth 133 35.3   34 30.9   88 49.4 
Alcoholic drinks during pregnancy       
  Yes   39 10.3     9   8.2   32 18.0 
  No 338 89.7 101 91.8 146 82.0 
Maternal cigarette smoked since 
pregnancyb 
      
  Yes     9   2.4   56 50.9 160 89.9 
  No 368 97.6   54 49.1   18 10.1 
Multivitamin/prenatal vitamin used        
  Yes 188 49.9   36 32.7   73 41.0 
  No 189 50.1   74 67.3 105 59.0 
Public assistance a       
  Yes   65 17.2   42 38.5   64 36.0 
  No 312 82.8   67 61.5 114 64.0 
a Missing observations for maternal race other than White and African-American (n=10); marital status (n=1); and 
public assistance (n=1). 
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Table 11. Associations between CRP concentrations and preterm delivery 
 Preterm Delivery 
 Crude ORs (95% CI) Adjusted ORs (95% CI)a 
C-reactive Protein   
  per IQR (5.4 ng/ml) 0.96 (0.81 – 1.14) 0.95 (0.78 – 1.16) 
  <8 1 1 
  ≥8 1.20 (0.75 – 1.92) 1.30 (0.76 – 2.24) 
a Adjusted for BMI, and race 
 
Table 12. Associations between cotinine concentrations and CRP concentrations 
 CRP (<8, ≥8ng/ml) 
 Crude ORs (95% CI) Adjusteda ORs (95% CI) 
Cotinine (ng/ml)   
  <5 1 1 
  5 - <100 0.77 (0.43 – 1.37) 0.94 (0.44 – 2.01) 
  ≥100 0.87 (0.53 – 1.44) 0.95 (0.50 – 1.82) 
a Adjusted for BMI, gestational weeks at baseline, age, and race 
 
Table 13. Associations between cotinine concentrations and preterm delivery 
 Preterm Delivery 
 Model 1 Model 2 Model 3 Model 4 
 Crude ORs  
(95% CI) 
Adjusteda ORs 
(95% CI) 
Crude ORs  
(95% CI) 
Adjusteda ORs 
(95% CI) 
Cotinine (ng/ml)     
  <5 1 1 1 1 
  5 - <100 1.30 (0.78 – 2.17) 1.15 (0.68 – 1.99) 1.32 (0.79 – 2.20) 1.17 (0.69 – 2.00) 
  ≥100 1.66 (1.10 – 2.48) 1.72 (1.12 – 2.64) 1.68 (1.12 – 2.52) 1.76 (1.14 – 2.70) 
C-reactive Protein     
  <8 - - 1 1 
  ≥8 - - 1.25 (0.78 – 2.02) 1.46 (0.87 – 2.47) 
a Adjusted for BMI, and race 
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5.0  AMBIENT AIR POLLUTION EXPOSURE AND BLOOD PRESSURE CHANGES 
DURING PREGNANCY 
5.1 ABSTRACT 
Maternal exposure to ambient air pollution has been associated with adverse birth outcomes such 
as preterm delivery but only one study to date has linked air pollution to blood pressure (BP) 
changes during pregnancy, a period of dramatic cardiovascular function changes. The authors 
examined whether trimester specific exposure to particles of less than 10 µm (PM10) or 2.5 µm 
diameter (PM2.5), and ozone affect systolic (SBP) and diastolic (DBP) early to late pregnancy BP 
changes in a prospectively followed cohort of 1,684 pregnant women in Allegheny County, PA. 
Air pollution measures for maternal ZIP code areas were derived using Kriging interpolation. 
First but not second or third trimester PM10 and ozone exposure were associated with early to 
late pregnancy BP changes, most strongly in non-smokers. The authors estimated increases in 
SBP of 1.58 mmHg (95% CI=0.72 to 2.44) or 3.14 (95% CI=1.33 to 4.96) and in DBP of 0.53 
mmHg (95% CI=0.39 to 1.45) or 1.23 (95% CI=0.29 to 2.74) per interquartile increase in PM10 
or O3 respectively during the first trimester in non-smokers. Our novel finding suggests that first 
trimester air pollution exposures may affect birth outcomes adversely via BP increases in the 
later part of pregnancy. 
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5.2 BACKGROUND 
Pregnancy associated hypertension, defined as systolic blood pressure (SBP) ≥140 mmHg or 
diastolic blood pressure (DBP) ≥90 mmHg during the second half of pregnancy, is one of the 
leading causes of perinatal and maternal mortality and morbidity 136-138. When pregnancy 
associated hypertension is accompanied by proteinuria after 20 weeks of gestation, the disorder 
is termed preeclampsia, a pregnancy complication associated with increased risk of not only 
preterm birth and intrauterine growth restriction (IUGR) 139,140, but also cardiovascular disease in 
mothers later in life 141. Although reduced placental perfusion due to abnormal vascular 
remodeling is proposed as a root cause of preeclampsia, the etiology and pathophysiology of this 
disorder are largely unknown 137. 
A growing body of research has linked changes in blood pressure (BP) to ambient air 
pollution, especially particulate matter (PM), among elderly persons with preexisting cardiac 
disease, and healthy individuals 142,143. Some short term exposure studies have reported positive 
associations between PM air pollution and BP 142,143, while others  have reported the reverse, i.e., 
increases in PM exposure associated with decreases in BP 144-146 or no association 147,148. To date 
only one study has examined whether increases in particulate air pollution are associated with BP 
changes in women who are pregnant, even though pregnancy is a period of dramatic changes in 
maternal anatomy, physiology, and metabolism to support the development of the fetus.  
Pregnancy hormones including progesterone and prostaglandins, and rennin-angiotensin-
aldosterone system play important roles in the BP changes during pregnancy 149,150. During 
normal pregnancy,  blood volume as well as cardiac output starts to increase by 6 weeks of 
gestation to adequately perfuse and oxygenate the fetal and maternal tissues 151. These profound 
cardiovascular adaptations result in changes in BP during gestation, with decreased SBP and 
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DBP in early pregnancy measured until approximately 20 weeks of gestation, after which BP 
increases and returns to non-pregnancy levels at term in normal pregnancies 152,153.  
To date studies of air pollution and reproductive outcomes have focused mainly on 
outcomes such as preterm birth, low birth weight and small for gestational age (SGA) infants, 
with only three studies focusing on preeclampsia 92,154,155 and a single study suggesting a positive 
association with BP changes during pregnancy 156. Positive associations have also been reported 
between air pollutants and preeclampsia risk. Here we examine whether and how particulate air 
pollution (including PM10 and PM2.5) and ozone exposures are associated with BP changes in a 
cohort of 1,684 pregnant women followed throughout pregnancy to delivery. 
5.3 MATERIALS AND METHODS 
5.3.1 Study Population 
Study subjects were selected from the Prenatal Exposures and Preeclampsia Prevention study 
(PEPP), which enrolled 2,211 healthy women from clinics and private practices, aged 14-44 in 
early pregnancy (<16 weeks of gestation) and followed to delivery between 1997 and 2001 in 
Pittsburgh, PA. Women were interviewed twice, once at the first visit and then again postpartum, 
to obtain specific information including sociodemographic characteristics and reproductive and 
medical history at baseline, and information on diet, cigarette smoking and consumption of 
alcohol in both interviews. Maternal residential ZIP code at the time of delivery and BP (both 
SBP and DBP) and maternal weight during each prenatal care visit were abstracted from hospital 
records. BP was taken by the clinic nursing staff with the patient seated and the cuff at the level 
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of the subject’s heart. We excluded women with chronic hypertension and diabetes (N=32) 
because the BP of these women may respond differently to an exposure challenge and may have 
had relatively poor cardiovascular function. We also excluded women without BP measurements 
before 20 weeks of gestation or at least two measurements after 20 weeks (N=84). Additionally, 
multiparous women who were second-time participants in the PEPP study and those with a 
maternal residential ZIP code outside of Allegheny County, PA were excluded. A total of 1,684 
women were included. This study has been approved by the Institutional Review Board at the 
University of Pittsburgh and written informed consent has been obtained from all participants.  
5.3.2 Exposure Assessment 
Maternal exposure to ambient air pollution during prenatal care was estimated based on air 
monitoring data, including carbon monoxide (CO), nitrogen dioxide (NO2), sulfur dioxide (SO2), 
ozone (O3), PM10, and PM2.5 for Allegheny County (AC) and its neighboring counties (within 50 
km of the AC boundary), collected by the AC Health Department (ACHD) and the US 
Environmental Protection Agency (EPA) between 1996 and 2001. PM2.5 and PM10 were 
collected daily or every third or sixth day at 23 monitoring stations (including 13 monitoring 
stations in AC) from 1999 to 2001 and PM10 data at 40 stations (including 18 monitoring stations 
in AC) from 1997 to 2001, respectively. For gaseous pollutants, SO2 measurements were 
available from 32 stations (including 7 monitoring stations in AC), and O3 from 15 stations 
(including 3 monitoring stations in AC), while only 11 stations measured NO2 and CO during the 
study period (with 3 and 2 monitoring stations respectively in AC). The air pollution data include 
one-hour concentrations for CO, NO2, O3, and SO2; and 24-hour concentrations for PM2.5 and 
PM10.   
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Daily air pollution concentrations were estimated relying on the space-time ordinary 
Kriging (STOK) interpolation method at each centroid of a grid, sized 13.4 m2, in AC by fitting 
the spatial and temporal variograms separately using a spherical semivariogram model. We also 
combined the individual spatial and temporal variograms into one space-time variogram by 
fitting a general product-sum model 157.  
To calculate exposure concentrations for each woman, we first calculated the date of each 
prenatal visit based on gestational age (assessed by ultrasound and estimated day of delivery) at 
each visit and date of the delivery of her infant. We then calculated exposure concentrations for 
each pollutant during each trimester by averaging the estimated daily concentration for each 
trimester at each centroid of the grid within each ZIP code. In addition, we calculated air 
pollutant concentrations 0 to 7 days (lag0 – lag7) and mean concentrations for a period of 7 days 
(i.e., 8-day averages) prior to the BP measurement (prenatal visit date) based on maternal ZIP 
code to evaluate associations between short-term exposures and BP changes.   
5.3.3 Statistical Analysis 
We calculated SBP and DBP changes for each woman, subtracting the average of the respective 
BP measurements in the first 20 weeks of gestation from the average of the 2 measurements 
taken during the last prenatal care visits. Additionally, we calculated average pulse pressure (PP) 
changes for each woman, subtracting the average PP in the third trimester (average SBP-DBP in 
the third trimester) from the average PP in the first 20 weeks of gestation (average SBP-DBP in 
the first 20 weeks of gestation).  Among 1,684 women, 6% had only one SBP or DBP 
measurement available before 20 weeks of gestation. We coded BP measurements outside a 
reasonable range as missing (<1% of measurements), i.e., SBP below 40 mmHg or above 250 
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mmHg; DBP below 40 mmHg or above 180 mmHg. To examine associations between trimester-
specific air pollution exposures and SBP and DBP changes during pregnancy, we employed 
multiple linear regression analyses with a robust variance estimator to account for clustering of 
maternal residences within ZIP codes. When examining associations between short term air 
pollution exposures and BP changes, we fitted linear mixed-effects models using maximum 
likelihood (ML) estimation with random intercepts and a spherical correlation structure 
(range=60 days, nugget effect=0.8) to account for correlations between visits at different 
intervals. We evaluated short-term (lag0 to lag7, and 8-day averages) and longer term (trimester 
specific averages) air pollution exposures using continuous measures, and report increases per 
interquartile range (IQR).  
In all models, we controlled for maternal age (years), race (White, African-American), 
pre-pregnancy body mass index (BMI) (kg/m2), parity (first birth, second or subsequent birth), 
number of cigarettes smoked during pregnancy, multivitamin or prenatal vitamin use (yes/no), 
and season (spring, summer, fall, winter) and year of entering the study (for PM10 and other 
pollutants spanning: 1997-2001; for PM2.5: 1999-2001). Other potential confounders, including 
marital status, alcohol intake during pregnancy, maternal education, household income, public 
assistance, and gestational weeks, were not included because these factors did not change the 
estimates for pollutants by more than 10 percent when included in preliminary analyses 105. 
Previous studies reported different BP patterns for smokers and non-smokers during 
pregnancy 158,159. In addition, women who develop gestational hypertension and preeclampsia 
also may exhibit different BP patterns. Thus, we conducted sensitivity analyses restricted to only 
those women without pregnancy-induced hypertension (preeclampsia and gestational 
hypertension) and to non-smokers only. Moreover, race may modify associations between air 
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pollution and BP changes. We investigated effect modification by race (mainly Africa-American 
and Caucasian) using interaction terms in our models and stratified analyses. 
We relied on the last two measurements of BP taken during prenatal care visits that were 
on average 1.4 weeks apart (SD=1.2) to calculate early to late pregnancy BP changes (at 36.7 
weeks (SD=2.8) mean gestation). For women who delivered preterm (i.e., before 37 gestational 
weeks), we averaged BP measurements from earlier gestational weeks than for women who 
delivered at term. We also performed sensitivity analyses in which we only included 
measurements for term birth (gestational weeks 37 weeks and greater). 
5.4 RESULTS 
The mean maternal age in our study population was 24.9 years (SD=5.9) at enrollment and a 
mean pre-pregnancy BMI was 25.4 kg/m2 (Table 14). The majority of our study participants was 
of white race (63%), did not smoke during pregnancy (68%), and used multivitamins or prenatal 
vitamins (86%). Average SBP and DBP increased as gestational age increased. For example, the 
average SBP and DBP in the first 20 weeks of gestation were 112.5 mmHg (SD=8.3) and 68.4 
mmHg (SD=6.1), respectively while the average SBP and DBP increased to 117.2 mmHg 
(SD=10.1) and 72.6 mmHg (SD=7.7), respectively late in the third trimester. African-American 
has slightly higher average SBP and DBP before 20 weeks of gestation than White (SBP: 113.2 
mmHg (SD=8.2), 112.3 mmHg (SD=8.4) respectively; DBP: 68.7 mmHg (SD=6.0), 68.3 mmHg 
(SD=6.2) respectively).However, the average SBP and DBP in the third trimester among White 
are higher than African-American (SBP: 117.5 mmHg (SD=10.2), 116.8 mmHg (SD=9.9) 
respectively; DBP: 73.0 mmHg (SD=7.7), 71.9 mmHg (SD=7.7) respectively). Among our study 
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participants, 32 (2%) developed preeclampsia and 110 (7%) received a diagnosis of gestational 
hypertension. 
Table 15 summarizes means and correlations of pollutant concentrations in the first 
trimester. Average first trimester PM10, PM2.5, and O3 concentrations were strongly positively 
correlated with each other but negatively correlated with CO, SO2, and NO2. 
5.4.1 Ambient air pollution and blood pressure changes 
An IQR increase in PM10 was associated with a 1.02 mmHg increase in average SBP (95% 
CI=0.13 to 1.91) and a 0.40 mmHg increase in average DBP (95% CI=-0.27 to 1.06) in adjusted 
single-pollutant models for the entire study population (Table 16). In contrast, we found no 
association between first trimester PM2.5 and early to late pregnancy SBP changes, and a weak 
association with DBP changes. We also saw strong associations between O3 and changes in both 
SBP and DBP from early to late pregnancy. For example, an IQR increase in O3 was associated 
with a 2.04 mmHg (95% CI=0.47 to 3.62) and a 0.79 mmHg (95% CI=-0.36 to 1.94) increases in 
SBP and DBP, respectively.  
When we restricted our analyses to non-smokers, effect estimates were larger in size for 
PM10, PM2.5, and O3. For non-smokers, adjusted single-pollutant models suggested a 1.58 mmHg 
(95% CI=0.72 to 2.44) increase in SBP and a 0.53 mmHg (95% CI=-0.39 to 1.45) increase in 
DBP per IQR increase in PM10 during the first trimester (Table 16). Similarly, associations 
between air pollution exposure and BP changes were stronger for O3 in non-smokers, with 3.14 
mmHg (95% CI=1.33 to 4.96) and 1.23 mmHg (95% CI=-0.29 to 2.74) increases in SBP and 
DBP, respectively, per IQR increase in O3. We observed weak positive associations between 
second and third trimester air pollution exposure to PM10, PM2.5, and O3 and early to late 
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pregnancy BP changes; all 95% confidence intervals included the null values. For example, we 
observed 0.46 mmHg (95% CI=-1.03 to 1.95) and 0.37 mmHg (95% CI=-0.52 to 1.26) increases 
in SBP per IQR increase in PM10 during the second and third trimester in adjusted single-
pollutant models for non-smokers. For CO, SO2 and NO2, associations were null for both the 
entire population and non-smokers only (results not shown). 
We observed positive associations between first trimester PM10 and O3 and PP changes 
(Table 17). The associations were stronger when we included the analyses for non-smokers. For 
example, an IQR increase in PM10 was associated with a 0.62 mmHg increase in average PP 
(95% CI=-0.36 to 1.61) for the entire population and a 1.05 mmHg increase in average PP (95% 
CI=-0.13 to 2.24) in adjusted single-pollutant models for non-smokers. 
 Generally, effect estimates for PM10, PM2.5, O3 and BP changes changed only slightly 
when we excluded women with preeclampsia and gestational hypertension disorders in adjusted 
single-pollutant models (results not shown). Sensitivity analyses examining associations only 
among women who delivered at term (37 weeks of gestation and greater) produced almost 
identical estimates (results not shown). When we stratified our results by race, first trimester 
PM10 and ozone affected DBP change only in Caucasians and not in African-Americans, while 
SBP increases were seen in both races. For PM2.5 we did not observe associations between first 
trimester exposures and early to late pregnancy BP changes in either racial subgroup (results not 
shown).  
None of the short term air pollution exposure measures (lag1 to lag7 and 8-day averages 
prior to BP measurement) was associated with SBP or DBP changes during pregnancy (results 
not shown). 
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5.5 DISCUSSION 
We identified associations between first trimester exposure to PM10 and O3 air pollution and 
increases in mean SBP and DBP in early to late pregnancy in our cohort of pregnant women. 
Associations between particulate and O3 air pollution and mean BP changes generally were 
stronger when we restricted our analyses to non-smokers. Our study is among the first to assess 
the relation between air pollution exposure and BP changes among pregnant women, and our 
findings provide new insights on how first trimester air pollution may adversely affects birth 
outcomes.  
 A growing number of experimental studies as well as observational epidemiological 
studies have examined possible links between ambient air pollution and BP changes in healthy 
individuals, the elderly and people with cardiovascular diseases 142,143,145,146,160,161. However, only 
one study has examined air pollution exposure and BP changes in pregnant women 156. The 
mechanisms by which air pollution could affect BP and BP changes over time likely differ and 
might be more complex than those in non-pregnant populations. In most aging populations, 
clinical changes in BP are most commonly attributed to arterial vascular degeneration; however, 
in pregnant women, changes in BP result from systemic adaptation necessary to accommodate 
the needs and presence of the developing fetus. During normal pregnancy, maternal blood 
volume begins to increase in early pregnancy and increases approximately 25% to 50% in 
volume by 32 weeks of gestation, in order to support maternal and fetal circulation 151. These 
blood volume increases are accompanied by decreases in systemic vascular resistance (SVR). 
The lowest SVR occurs in the first and second trimester, and increases again until term; this is 
reflected by both lower SBP and DBP in early pregnancy and a gradual increase during the late 
second and throughout the third trimester 149.  
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  A recent Dutch study reported associations between higher PM10 exposures in the second 
and third but not first trimester and increased SBP during the same trimester  156. Additionally, 
they reported that NO2 exposure increased SBP in all three trimesters. These results cannot easily 
be compared to our findings because the outcome of interest in our study was defined as early to 
late pregnancy BP changes while the Dutch study only examined trimester exposures in a cross-
sectional manner, while we examined associations between early pregnancy (first trimester) 
exposures and longitudinal BP changes. Furthermore the Dutch exposure assessment relied on 
spatiotemporal dispersion modeling that accounts for traffic point sources including NO2 
emissions from vehicles; this detailed assessment of spatial variation due to traffic sources could 
not be achieved in AC.  
Studies on air pollution and adverse birth outcomes have reported most consistent results 
for particulate air pollution and preterm birth 26,162. Recently, a larger hospital-based study in 
California, USA, of local traffic-generated air pollution and preeclampsia reported odds ratios of 
1.33 (95% CI=1.18 to 1.49) and 1.42 (95% CI=1.26 to 1.59) for preeclampsia in the highest 
exposure quartiles for NOx and PM2.5, respectively, during pregnancy 92. Although it has been 
hypothesized that particulate air pollution may induce BP changes that result in preterm birth 57, 
and pregnancy-related hypertension is one of the risk factors for and key signs of  preeclampsia, 
the insufficient sample size of our cohorts (with 142 preterm births and 32 cases of 
preeclampsia) precluded us from examining whether BP changes mediate the associations 
between air pollution and these adverse outcomes. Nevertheless, our novel findings that PM10 
and O3 air pollution are associated with mean increases in BP from early to late pregnancy 
provide some new insight into possible pathways linking air pollution and pregnancy outcomes.  
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Pregnancy associated hypertension has been associated with increased risks of preterm 
birth, low birth weight, SGA, still birth, and neonatal mortality 163,164. In contrast, women with 
preeclampsia delivering after 37 weeks of gestation delivered an excess of large for gestational 
age infants 164. The impact of pregnancy associated hypertension on fetal growth is multifactorial 
and complex. Zhang et al. (2007) reported that even in normotensive women, a rise in SBP or 
DBP from early pregnancy (average BP between 12 and 19 weeks of gestation) to mid third 
trimester (average BP between 30 and 34 weeks of gestation) is associated with spontaneous 
preterm birth and a higher risk of preterm birth with a greater increase in BP. They also reported 
that women who had late spontaneous preterm birth (defined as delivery between 34 and 36 
weeks of gestation) experienced a 3.6 mmHg (95% CI=2.5 to 4.8) and 3.1 mmHg (95% CI=1.7 
to 4.4) higher rise in DBP and SBP, respectively, than women with term births 165. In our study, 
an IQR increase in PM10 and O3 exposure in the first trimester was associated with an increase in 
SBP of 1.6 mmHg (95% CI=0.72 to 2.44) in all women and a 3.1 mmHg (95% CI=1.33 to 4.96) 
increase in non-smokers between early and late pregnancy; these increments are similar in size to 
those reported previously. It is possible that air pollution could be related to an increased risk for 
preterm delivery through such increases in BP.   
We did not find associations between mean BP changes and gaseous combustion related 
air pollutants, i.e., CO, NO2, and SO2, which previous studies have linked to adverse birth 
outcomes 26,89. Our null findings for these pollutants and BP are most likely due to our inability 
to sufficiently capture the spatial distribution of these pollutants with a  small number of 
monitoring stations measuring CO and NO2 (2 and 3 monitoring stations, respectively) in AC.  
For pollutants that are highly spatially heterogeneous, such as CO, a few monitoring stations will 
not be able to represent local sources adequately, resulting in poor spatial resolution. 
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Furthermore, while we observed a positive association of PM2.5 with mean BP changes, the 
estimated effect size was much smaller than for PM10; due to fewer years of monitoring for fine 
particles, our small sample size limited our analyses.  
Trimester specific air pollution exposures have been evaluated in a number of air 
pollution and birth outcomes studies, and the most consistent evidence points to the importance 
of first and third trimester exposures for preterm and low birth weight outcomes 26,45,89,162. 
Clinical studies have reported that first trimester growth restriction (determined by crown to 
rump length) is significantly related to increased risks of preterm birth, SGA at birth, and low 
birth weight 166-168. Further it is in the first half of pregnancy that the vascular remodeling of 
maternal vessels supplying the intervillus space is completed. A failure of these adaptations to 
occur normally is associated with IUGR, preeclampsia and preterm birth. Our findings that first 
trimester particulate and O3 air pollution exposures were associated with mean BP increase 
during pregnancy, with little or no indication of association in either the second or third 
trimester.  This suggests that air pollution exposure in the first trimester may be more relevant 
than exposures later in pregnancy. 
A limitation of our study is that BP measurements may have been subject to other factors 
that might increase BP in the short term, such as anxiety and caffeine consumption at the time of 
a prenatal visit. However, our analyses are based on averages of BP measurements at several 
visits for most women during the first 20 weeks of gestation and one measurement each at two 
visits late in the third trimester. We expect this approach to have reduced variability of BP due to 
short term factors.  In addition, we did not have maternal residential history during pregnancy 
and relied on residential information at birth to assess air pollution exposure, which may have 
resulted in exposure measurement error. However, because participants in this longitudinal study 
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received their prenatal care and delivered in the same hospital, we believe that our assumption is 
reasonable that most women in our study either did not move or moved only within the same 
neighborhood (or ZIP code) during pregnancy, as also suggested by Chen et al. (2010) 112. 
5.6 CONCLUSIONS 
In summary, first trimester exposure to PM10 and ozone air pollution during pregnancy was 
positively associated with mean SBP and DBP changes, and these associations were stronger 
when we restricted our analyses to non-smokers. Our results suggest that BP changes may play a 
role in mediating reported associations between air pollution and adverse birth outcomes.   
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5.7 TABLES 
Table 14. Demographics and major risk factors in the study population (N=1,684) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Continuous Measures Mean std 
Pre-pregnancy BMI (kg/m2)   25.4   6.4 
Maternal age (years)   24.9   5.9 
Average SBP (mm-Hg) in the first 20 weeks of 
gestation 
112.5 
(range=70-155)   8.3 
Average DBP (mm-Hg) in the first 20 weeks of 
gestation 
  68.4 
(range=40-94)   6.1 
Average SBP (mm-Hg) in the last two blood 
pressure measurements 
117.2 
(range=79-170) 10.1 
Average DBP (mm-Hg) in the  last two blood 
pressure measurements 
  72.6 
(range=50-130)   7.7 
Categorical Measures N % 
Maternal race/ethnicity   
  White 1,040 63 
  African American    610 37 
Parity   
  First birth  1,033 61 
  Second or subsequent birth    651 39 
Smoking status  during pregnancy   
  Yes    527 32 
  No 1,104 68 
Multivitamin or prenatal vitamin used   
  Yes 1,440 86 
  No    143   8 
  Missing     101   6 
Year entering the study   
  1997    197 12 
  1998    299 18 
  1999    371 22 
  2000     498 29 
  2001    319 19 
Season entering the study   
  Spring (March-May)    523 31 
  Summer (June-August)    428 25 
  Fall (September-November)    373 22 
  Winter (December-February)    360 22 
Preeclampsia   
  Yes      32   2 
  No 1,652 98 
Gestational Hypertension   
  Yes    110   7 
  No 1,574 93 
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Table 15. The descriptive statistics of first trimester air pollution exposures 
 
 
 
 
a For years of 1999, 2000, and 2001 
   Percentile  Pearson Correlation 
Pollutants Mean ± SD IQR 0th 25th 50th  75th 95th 100th  PM10 PM2.5 O3 NO2 SO2 CO 
PM10 (µg/m3) 26.1 ± 4.8   7.3 13.8 22.4 25.4 29.6 34.7 40.0  1      
PM2.5 (µg/m3)a 16.5 ± 2.7   3.8 10.8 14.3 16.2 18.1 21.6 24.7   0.9 1     
O3 (ppb) 22.7 ± 8.6 15.3   6.3 14.8 22.9 30.1 35.6 42.7   0.7  0.5 1    
NO2 (ppb) 18.7 ± 2.9   4.0   9.0 16.7 18.8 20.7 23.3 26.1  -0.3 -0.5 -0.5 1   
SO2 (ppb)   8.6 ± 2.4   3.6   3.3   6.7   8.1 10.3 12.8 17.5  -0.3 -0.3 -0.6 0.3 1  
CO (ppm)   0.5 ± 0.2   0.3   0.1   0.3   0.4   0.6   0.8   1.1  -0.1 -0.2 -0.4 0.7 0.3 1 
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Table 16. Increase in average blood pressure (in mmHg)a  per IQR increase in first trimester air pollution exposurea 
  Change in BP (95% CI) 
 N Crude Adjusteda 
For the entire population    
  PM10 (µg/m3)    
    SBP 1,684 0.88 ( 0.30 to 1.45) 1.02 ( 0.13 to 1.91) 
    DBP 1,684 0.38 (-0.16 to 0.92) 0.40 (-0.27 to 1.06) 
  PM2.5 (µg/m3)    
    SBP 1,128 0.12 (-0.71 to 0.94) 0.01 (-1.08 to 1.11) 
    DBP 1,128 0.23 (-0.42 to 0.87) 0.29 (-0.49 to 1.07) 
  O3 (ppb)    
    SBP 1,684 1.33 ( 0.57 to 2.09) 2.04 ( 0.47 to 3.62) 
    DBP 1,684 0.75 (-0.05 to 1.55) 0.79 (-0.36 to 1.94) 
For non-smokers    
  PM10 (µg/m3)    
    SBP 1,104 0.91 ( 0.26 to 1.56) 1.58 ( 0.72 to 2.44) 
    DBP 1,104 0.33 (-0.30 to 0.95) 0.53 (-0.39 to 1.45) 
  PM2.5 (µg/m3)    
    SBP   726 0.17 (-0.83 to 1.17) 0.44 (-0.73 to 1.61) 
    DBP   726 0.33 (-0.37 to 1.02) 0.50 (-0.27 to 1.28) 
  O3 (ppb)    
    SBP 1,104 1.41 ( 0.51 to 2.32) 3.14 ( 1.33 to 4.96) 
    DBP 1,104 0.65 (-0.30 to 1.60) 1.23 (-0.29 to 2.74) 
For smokers    
  PM10 (µg/m3)    
    SBP 527 0.71 (-0.38 to 1.79) 0.19 (-1.64 to 2.01) 
    DBP 527 0.25 (-0.57 to 1.08) 0.37 (-0.91 to 1.65) 
  PM2.5 (µg/m3)    
    SBP 357 -0.31 (-1.49 to 0.87) -0.50 (-2.24 to 1.25) 
    DBP 357 -0.26 (-1.66 to 1.14) 0.11 (-1.94 to 2.17) 
  O3 (ppb)    
    SBP 527 1.26 (-0.15 to 2.66) 0.29 (-2.00 to 2.59) 
    DBP 527 0.87 (-0.36 to 2.09) 0.47 (-1.85 to 2.79) 
a All models were adjusted for: maternal age, race, parity, number of cigarettes smoked during pregnancy (for the 
entire population only), multivitamin or prenatal vitamin used during pregnancy, maternal pre-pregnancy BMI, and 
season and year of enrolment (for PM10 and O3: 1997 to 2001; for PM2.5: 1999 to 2001) 
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Table 17. Increase in average pulse pressure (PP) (in mmHg) per IQR increase in the first trimester air pollution 
exposure 
  Change in PP (95% CI) 
 N Crude Adjusteda 
For the entire population    
  PM10 (µg/m3) 1683 0.50 (-0.05 to 1.05) 0.62 (-0.36 to 1.61) 
  PM2.5 (µg/m3) 1127 -0.12 (-0.91 to 0.68) -0.28 (-1.44 to 0.88) 
  O3 (ppb) 1683 0.58 (-0.09 to 1.25) 1.25 (-0.16 to 2.67) 
For non-smokers    
  PM10 (µg/m3) 1103 0.58 (-0.07 to 1.23) 1.05 (-0.13 to 2.24) 
  PM2.5 (µg/m3) 725 -0.16 (-1.0 to 0.68) -0.06 (-1.27 to 1.15) 
  O3 (ppb) 1103 0.75 (-0.07 to 1.58) 1.92 (0.14 to 3.70) 
For smokers    
  PM10 (µg/m3) 527 0.46 (-0.54 to 1.45) -0.19 (-1.88 to 1.51) 
  PM2.5 (µg/m3) 357 -0.05 (-1.55 to 1.45) -0.61 (-3.15 to 1.93) 
  O3 (ppb) 527 0.39 (-0.96 to 1.73) -0.18 (-2.71 to 2.36) 
a All models were adjusted for: maternal age, race, parity, number of cigarettes smoked during pregnancy (for the 
entire population only), multivitamin or prenatal vitamin used during pregnancy, maternal pre-pregnancy BMI, and 
season and year of enrolment (for PM10 and O3: 1997 to 2001; for PM2.5: 1999 to 2001) 
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6.0  SUMMARY AND CONCLUSIONS 
This project has been developed to explore several possible mechanisms link ambient air 
pollution and adverse birth outcomes. In addition, the project has also examined the role of 
systemic inflammation in the pathway of smoking and preterm birth. The results showed positive 
associations between (1) particulate (both PM2.5 and PM10) and ozone air pollution and elevated 
CRP concentrations in non-smoking women during early pregnancy, (2) first trimester exposure 
to PM10 and ozone air pollution contributed to increases in mean systolic and diastolic early to 
late pregnancy blood pressure, and (3) no evidence that systemic inflammation mediates the link 
between smoking and preterm delivery. These findings provide some new evidence that 
associations between particulate air pollution and adverse birth outcomes may be mediated by 
systemic inflammation and blood pressure changes, and further studies with larger study 
population are needed to clarify the role of systemic inflammation on the pathway of smoking 
and preterm delivery. 
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APPENDIX 
SPACE-TIME KRIGING 
Space-time ordinary Kriging (STOK) interpolation method to estimate daily air pollution 
concentrations at the zip code level by averaging the estimated concentration of pollution at each 
centroid of the grid (size of 13.4 m2) within each zip code was performed. Spatial and temporal 
variograms were fitted into a spherical semivariogram model separately based on temporally 
detrended residuals (below A.1 to A.6). In addition, we combined the spatial and temporal 
variograms to a space-time variogram by fitting a general product-sum model. This modification 
of space-time ordinary kriging has been shown to increase mean precision compared to ordinary 
kriging.  
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A.1 SPACE-TIME VARIOGRAM-PM10 
Distribution of PM10 monitoring sites
1
 
Semi-variogram:  Spherical model
• If h=0 then γ (h;θ)=0;
• If 0< h ≤ as then γ (h;θ)=C0+Cs[(3/2)(h/as)-
(1/2)(h/as)3];
• If h > as then γ (h;θ)=C0+Cs
H=distance
G
am
m
a
Sill = C0 + Cs
Nugget = C0
Cs
Range=a
2
 
Spatial Semivariogram
3  
Spatial Semivariogram (Cont.)
4
 
Spatial Semivariogram (Cont.)
Results from model fit:  
model             psill range
1   Nug 0.03245324    0.00000
2   Sph 0.21589752   38.83007
Nugget effect= 0.03245324 
Sill=0.03245 + 
0.21590=0.24835
Range=38.83007 (Km)
5  
Temporal Semivariogram
6
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Temporal Semivariogram (Cont.)
7  
Temporal Semivariogram (Cont.)
Results from model fit:  
model           psill range
1   Nug 0.06190351   0.000000
2   Sph 0.20594041   3.649337
Nugget effect= 0.06190351
Sill= 0.0619035 + 0.2059404
=0.2678
Range=3.649 (days)
8
 
Spatial-Temporal Semi-variogram
(contour)
9  
Spatial-Temporal Semi-variogram
Sill=0.28
10
 
Spatiotemporal variogram model:              
• Coefficients
k1 = [Cs(0) + Ct(0) − Cst(0; 0)]/Cs(0)Ct(0);
k2 = [Cst(0; 0) − Ct(0)]/Cs(0);
k3 = [Cst(0; 0) − Cs(0)]/Ct(0):
*here Cs means sill
• Product Sum Model: 
Cst(hs; ht) = k1Cs(hs)Ct(ht) + k2Cs(hs) + k3Ct(ht)
γst(hs; ht) = [k2 + k1Ct(0)]γs(hs) + [k3 + k1Cs(0)]γt(ht) −  
k1γs(hs)γt(ht)
*Assume: Ks=1=(K2+K1Ct(0))
Kt=1=(K3+K1Cs(0))
11  
Variograms
• Semi-variogram (temporal):
– γ (h;θ)=C0+Cs[(3/2)(h/as)-(1/2)(h/as)3]
=0.0619 +0.20594[(3/2)(h/3.649)-(1/2)(h/3.649)3]
• Semi-variogram (Spatial):
– γ (h;θ)=C0+Cs[(3/2)(h/as)-(1/2)(h/as)3]
= 0.03245+0.21590[(3/2)(h/38.83)-(1/2)(h/38.83)3]
• Step2: Calculate Product Sum Model:
– γst(hs; ht) = [k2 + k1Ct(0)]γs(hs) + [k3 + k1Cs(0)]γt(ht) − 
k1γs(hs)γt(ht)
= γs(hs) + γt(ht) − 3.5507 γs(hs)γt(ht)
12
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A.2 SPACE-TIME VARIOGRAM-PM2.5 
Distribution of PM2.5 monitoring sites
1
 
Semi-variogram:  Spherical model
• If h=0 then γ (h;θ)=0;
• If 0< h ≤ as then γ (h;θ)=C0+Cs[(3/2)(h/as)-
(1/2)(h/as)3];
• If h > as then γ (h;θ)=C0+Cs
H=distance
G
am
m
a
Sill = C0 + Cs
Nugget = C0
Cs
Range=a
2
 
Spatial Semivariogram
3  
Spatial Semivariogram (Cont.)
4
 
Spatial Semivariogram (Cont.)
Results from model fit:  
model        psill range
1   Nug 0.01535773    0.00000
2   Sph 0.23274368   31.97886
Nugget effect=0.07657
Sill=(0.01536+0.2327)=0.24806
Range=31.97886 (Km)
5  
Temporal Semivariogram
6
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Temporal Semivariogram (Cont.)
7  
Temporal Semivariogram (Cont.)
Results from model fit:  
model      psill range
1   Nug 0.07959511   0.000000
2   Sph 0.18841311   3.602777
Nugget effect= 0.07959511
Sill= 0.079595+0.188413=0.268
Range=3.603 (days)
8
 
Spatial-Temporal Semi-variogram
(contour)
9  
Spatial-Temporal Semi-variogram
Nugget effect
= 0.08
Sill=0.28
10
 
Spatiotemporal variogram model:              
• Coefficients
k1 = [Cs(0) + Ct(0) − Cst(0; 0)]/Cs(0)Ct(0);
k2 = [Cst(0; 0) − Ct(0)]/Cs(0);
k3 = [Cst(0; 0) − Cs(0)]/Ct(0):
• Product Sum Model: 
Cst(hs; ht) = k1Cs(hs)Ct(ht) + k2Cs(hs) + k3Ct(ht)
γst(hs; ht) = [k2 + k1Ct(0)]γs(hs) + [k3 + k1Cs(0)]γt(ht) −  
k1γs(hs)γt(ht)
*Assume: Ks=1=(K2+K1Ct(0))
Kt=1=(K3+K1Cs(0))
11  
Variograms
• Semi-variogram (temporal):
– γ (h;θ)=C0+Cs[(3/2)(h/as)-(1/2)(h/as)3]
=0.0796 +0.1884[(3/2)(h/3.603)-(1/2)(h/3.603)3]
• Semi-variogram (Spatial):
– γ (h;θ)=C0+Cs[(3/2)(h/as)-(1/2)(h/as)3]
= 0.0154+0.2327[(3/2)(h/31.979)-(1/2)(h/31.979)3]
• Step2: Calculate Product Sum Model:
– γst(hs; ht) = [k2 + k1Ct(0)]γs(hs) + [k3 + k1Cs(0)]γt(ht) − 
k1γs(hs)γt(ht)
= γs(hs) + γt(ht) − 3.5508 γs(hs)γt(ht)
12
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A.3 SPACE-TIME VARIOGRAM-CO 
Distribution of CO monitoring sites 
1
 
Semi-variogram:  Spherical model
• If h=0 then γ (h;θ)=0;
• If 0< h ≤ as then γ (h;θ)=C0+Cs[(3/2)(h/as)-
(1/2)(h/as)3];
• If h > as then γ (h;θ)=C0+Cs
H=distance
G
am
m
a
Sill = C0 + Cs
Nugget = C0
Cs
Range=a
2  
Spatial Semivariogram
3
 
Spatial Semivariogram (Cont.)
4  
Spatial Semivariogram (Cont.)
Results from model fit:  
model       psill range
Nug 0.06272875      0.00000
Sph 0.46227815      22.50751
Nugget effect= 0.06272875
Sill= 0.06272875 + 0.46227815
= 0.5250069
Range= 22.50751 (km)
5  
Temporal Semivariogram
6  
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Temporal Semivariogram (Cont.)
7  
Temporal Semivariogram (Cont.)
Results from model fit:  
model     psill range
Nug 0.1787978       0.00000
Sph 0.2481167      12.06138
Nugget effect= 0.1787978
Sill= 0.1787978 + 0.2481167
= 0.4269145
Range= 12.06138 (days)
8
 
Spatial-Temporal Semi-variogram
(contour)
9  
Spatial-Temporal Semi-variogram
Sill=0.6
10  
Spatiotemporal variogram model:              
• Coefficients
k1 = [Cs(0) + Ct(0) − Cst(0; 0)]/Cs(0)Ct(0);
k2 = [Cst(0; 0) − Ct(0)]/Cs(0);
k3 = [Cst(0; 0) − Cs(0)]/Ct(0):
*here Cs means sill
• Product Sum Model: 
Cst(hs; ht) = k1Cs(hs)Ct(ht) + k2Cs(hs) + k3Ct(ht)
γst(hs; ht) = [k2 + k1Ct(0)]γs(hs) + [k3 + k1Cs(0)]γt(ht) −  
k1γs(hs)γt(ht)
*Assume: Ks=1=(K2+K1Ct(0))
Kt=1=(K3+K1Cs(0))
11  
Variograms
• Semi-variogram (temporal):
– γ (h;θ)=C0+Cs[(3/2)(h/as)-(1/2)(h/as)3]
=0.1787978 +0.2481167[(3/2)(h/12.06318)-(1/2)(h/12.06318)3]
• Semi-variogram (Spatial):
– γ (h;θ)=C0+Cs[(3/2)(h/as)-(1/2)(h/as)3]
= 0.06272875+0.46227815[(3/2)(h/22.5075)-(1/2)(h/22.5075)3]
• Step2: Calculate Product Sum Model:
– γst(hs; ht) = [k2 + k1Ct(0)]γs(hs) + [k3 + k1Cs(0)]γt(ht) − 
k1γs(hs)γt(ht)
= γs(hs) + γt(ht) − 1.570 γs(hs)γt(ht)
12  
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A.4 SPACE-TIME VARIOGRAM-NO2 
Distribution of NO2 monitoring sites
1  
Semi-variogram:  Spherical model
• If h=0 then γ (h;θ)=0;
• If 0< h ≤ as then γ (h;θ)=C0+Cs[(3/2)(h/as)-
(1/2)(h/as)3];
• If h > as then γ (h;θ)=C0+Cs
H=distance
G
am
m
a
Sill = C0 + Cs
Nugget = C0
Cs
Range=a
2  
Spatial Semivariogram
3  
Spatial Semivariogram (Cont.)
4  
Spatial Semivariogram (Cont.)
Results from model fit:  
model      psill range
Nug 0.06799291     0.0000
Sph 0.10314293     22.3977
Nugget effect= 0.06799291
Sill= 0.06799291 + 0.10314293
= 0.17113581
Range= 22.3977 (km)
5
 
Temporal Semivariogram
6  
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Temporal Semivariogram (Cont.)
7  
Temporal Semivariogram (Cont.)
Results from model fit:  
model       psill range
Nug 0.002035792    0.000000
Sph 0.175976225    2.304466
Nugget effect= 0.002035792
Sill= 0.002035792 + 0.175976225
= 0.178
Range= 2.304466 (days)
8  
Spatial-Temporal Semi-variogram
(contour)
9  
Spatial-Temporal Semi-variogram
Sill=0.25
10  
Spatiotemporal variogram model:              
• Coefficients
k1 = [Cs(0) + Ct(0) − Cst(0; 0)]/Cs(0)Ct(0);
k2 = [Cst(0; 0) − Ct(0)]/Cs(0);
k3 = [Cst(0; 0) − Cs(0)]/Ct(0):
*here Cs means sill
• Product Sum Model: 
Cst(hs; ht) = k1Cs(hs)Ct(ht) + k2Cs(hs) + k3Ct(ht)
γst(hs; ht) = [k2 + k1Ct(0)]γs(hs) + [k3 + k1Cs(0)]γt(ht) −  
k1γs(hs)γt(ht)
*Assume: Ks=1=(K2+K1Ct(0))
Kt=1=(K3+K1Cs(0))
11  
Variograms
• Semi-variogram (temporal):
– γ (h;θ)=C0+Cs[(3/2)(h/as)-(1/2)(h/as)3]
=0.0020 +0.175976[(3/2)(h/2.304)-(1/2)(h/2.304)3]
• Semi-variogram (Spatial):
– γ (h;θ)=C0+Cs[(3/2)(h/as)-(1/2)(h/as)3]
= 0.06799291+0.10314293[(3/2)(h/22.3977)-(1/2)(h/22.3977)3]
• Step2: Calculate Product Sum Model:
– γst(hs; ht) = [k2 + k1Ct(0)]γs(hs) + [k3 + k1Cs(0)]γt(ht) − 
k1γs(hs)γt(ht)
= γs(hs) + γt(ht) − 3.254 γs(hs)γt(ht)
12  
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A.5 SPACE-TIME VARIOGRAM-SO2 
Distribution of SO2 monitoring sites 
1  
Semi-variogram:  Spherical model
• If h=0 then γ (h;θ)=0;
• If 0< h ≤ as then γ (h;θ)=C0+Cs[(3/2)(h/as)-
(1/2)(h/as)3];
• If h > as then γ (h;θ)=C0+Cs
H=distance
G
am
m
a
Sill = C0 + Cs
Nugget = C0
Cs
Range=a
2  
Spatial Semivariogram
3  
Spatial Semivariogram (Cont.)
4  
Spatial Semivariogram (Cont.)
Results from model fit:  
model      psill range
Nug 0.07852457     0.00000
Sph 0.51667000    20.15494
Nugget effect= 0.07852457
Sill= 0.07852457 + 0.51667000
= 0.59519
Range= 20.15494 (km)
5  
Temporal Semivariogram
6  
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Temporal Semivariogram (Cont.)
7  
Temporal Semivariogram (Cont.)
Results from model fit:  
model     psill range
Nug 0.3367861   0.000000
Sph 0.2200411   3.935355
Nugget effect= 0.3367861
Sill= 0.3367861 + 0.2200411
= 0.556827
Range= 3.935355(days)
8  
Spatial-Temporal Semi-variogram
(contour)
9  
Spatial-Temporal Semi-variogram
Sill=0.65
10  
Spatiotemporal variogram model:              
• Coefficients
k1 = [Cs(0) + Ct(0) − Cst(0; 0)]/Cs(0)Ct(0);
k2 = [Cst(0; 0) − Ct(0)]/Cs(0);
k3 = [Cst(0; 0) − Cs(0)]/Ct(0):
*here Cs means sill
• Product Sum Model: 
Cst(hs; ht) = k1Cs(hs)Ct(ht) + k2Cs(hs) + k3Ct(ht)
γst(hs; ht) = [k2 + k1Ct(0)]γs(hs) + [k3 + k1Cs(0)]γt(ht) −  
k1γs(hs)γt(ht)
*Assume: Ks=1=(K2+K1Ct(0))
Kt=1=(K3+K1Cs(0))
11  
Variograms
• Semi-variogram (temporal):
– γ (h;θ)=C0+Cs[(3/2)(h/as)-(1/2)(h/as)3]
=0.336786 +0.220041[(3/2)(h/3.935)-(1/2)(h/3.935)3]
• Semi-variogram (Spatial):
– γ (h;θ)=C0+Cs[(3/2)(h/as)-(1/2)(h/as)3]
= 0.0785+0.51667[(3/2)(h/20.1549)-(1/2)(h/20.1549)3]
• Step2: Calculate Product Sum Model:
– γst(hs; ht) = [k2 + k1Ct(0)]γs(hs) + [k3 + k1Cs(0)]γt(ht) − 
k1γs(hs)γt(ht)
= γs(hs) + γt(ht) − 1.514755 γs(hs)γt(ht)
12  
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A.6 SPACE-TIME VARIOGRAM-O3 
Distribution of O3 monitoring sites 
1  
O3 time series plot 
2  
Divided O3 to separate time periods 
Time period Number of measurement Number of sites
91-305 6204 30
457-670 6822 34
822-1035 7075 34
1187-1400 7466 35
1553-1766 7661 36
1918-2131 7875 37
2283-2496 7442 35
3  
Calculate overall variogram
• Calculate variogram for each subset and each 
direction by weight number of pairs
• Sum of gammas
• Average the distance
• Calculate time- , space-, and time-space 
variograms in R
4  
Semi-variogram:  Spherical model
• If h=0 then γ (h;θ)=0;
• If 0< h ≤ as then γ (h;θ)=C0+Cs[(3/2)(h/as)-
(1/2)(h/as)3];
• If h > as then γ (h;θ)=C0+Cs
H=distance
G
am
m
a
Sill = C0 + Cs
Nugget = C0
Cs
Range=a
5  
Spatial Semivariogram
6  
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Spatial Semivariogram (Cont.)
7  
Spatial Semivariogram (Cont.)
Results from model fit:  
model      psill range
1   Nug 0.01857383  0.00000
2   Sph 0.08276187 26.09189
Nugget effect= 0.01857383
Sill= 0.01857383 + 0.08276187
= 0.101336
Range= 26.09189 (km)
8  
Temporal Semivariogram
9  
Temporal Semivariogram (Cont.)
10  
Temporal Semivariogram (Cont.)
Results from model fit:  
model       psill range
1   Nug 0.04131764   0.000000
2   Sph 0.07002842   2.147153
Nugget effect= 0.04131764
Sill= 0.04131764 + 0.07002842 
= 0.111346
Range= 2.147153 (days)
11  
Spatial-Temporal Semi-variogram
(contour)
12  
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Spatial-Temporal Semi-variogram
(contour)
13  
Spatial-Temporal Semi-variogram
Sill=0.15
14  
Spatiotemporal variogram model:              
• Coefficients
k1 = [Cs(0) + Ct(0) − Cst(0; 0)]/Cs(0)Ct(0);
k2 = [Cst(0; 0) − Ct(0)]/Cs(0);
k3 = [Cst(0; 0) − Cs(0)]/Ct(0):
*here Cs means sill
• Product Sum Model: 
Cst(hs; ht) = k1Cs(hs)Ct(ht) + k2Cs(hs) + k3Ct(ht)
γst(hs; ht) = [k2 + k1Ct(0)]γs(hs) + [k3 + k1Cs(0)]γt(ht) −  
k1γs(hs)γt(ht)
*Assume: Ks=1=(K2+K1Ct(0))
Kt=1=(K3+K1Cs(0))
15  
Variograms
• Semi-variogram (temporal):
– γ (h;θ)=C0+Cs[(3/2)(h/as)-(1/2)(h/as)3]
=0.0413 +0.07[(3/2)(h/2.147)-(1/2)(h/2.147)3]
• Semi-variogram (Spatial):
– γ (h;θ)=C0+Cs[(3/2)(h/as)-(1/2)(h/as)3]
= 0.01857 +0.0828[(3/2)(h/26.09)-(1/2)(h/26.09)3]
• Step2: Calculate Product Sum Model:
– γst(hs; ht) = [k2 + k1Ct(0)]γs(hs) + [k3 + k1Cs(0)]γt(ht) − 
k1γs(hs)γt(ht)
= γs(hs) + γt(ht) − 5.56 γs(hs)γt(ht)
16  
 
 
 
102 
BIBLIOGRAPHY 
1. Joseph KSaMSK. Recent trends in Canadian infant mortality rates: effect of changes in 
registration of live newborns weighing less than 500 g. CMAJ 1996;1555(8). 
2. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from 
infancy to adulthood. Lancet 2008;371(9608):261-9. 
3. Selling KE, et al.,. Hospitalizations in adolescence and early adulthood among Swedish 
men and women born preterm or small for gestational age. Epidemiology 2008;19(1). 
4. Butler REBaAS, ed. Preterm Birth: 
           Causes, Consequences, and Prevention The National Academies Press, 2007. 
5. Berkowitz GS, Papiernik E. Epidemiology of preterm birth. Epidemiol Rev 
1993;15(2):414-43. 
6. Kramer MS. Intrauterine growth and gestational duration determinants. Pediatrics 
1987;80(4):502-11. 
7. LaMarca BD, Ryan MJ, Gilbert JS, Murphy SR, Granger JP. Inflammatory cytokines in 
the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep 
2007;9(6):480-5. 
8. Belo L, Santos-Silva A, Caslake M, Cooney J, Pereira-Leite L, Quintanilha A, Rebelo I. 
Neutrophil activation and C-reactive protein concentration in preeclampsia. Hypertens 
Pregnancy 2003;22(2):129-41. 
9. Foulon W, Van Liedekerke D, Demanet C, Decatte L, Dewaele M, Naessens A. Markers 
of infection and their relationship to preterm delivery. Am J Perinatol 1995;12(3):208-11. 
10. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, Wians FH, 
Jr., Grundy SM, de Lemos JA. Race and gender differences in C-reactive protein levels. J 
Am Coll Cardiol 2005;46(3):464-9. 
11. Pitiphat W, Gillman MW, Joshipura KJ, Williams PL, Douglass CW, Rich-Edwards JW. 
Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol 
2005;162(11):1108-13. 
12. Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective 
study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J 
Hypertens 2004;17(2):154-60. 
13. Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and 
preeclampsia: the potential role of inflammation. Obstet Gynecol 2001;98(5 Pt 1):757-62. 
14. Mamelle N, Laumon B, Lazar P. Prematurity and occupational activity during pregnancy. 
Am J Epidemiol 1984;119(3):309-22. 
15. Saurel-Cubizolles MJ, Kaminski M, Llado-Arkhipoff J, Du Mazaubrun C, Estryn-Behar 
M, Berthier C, Mouchet M, Kelfa C. Pregnancy and its outcome among hospital 
103 
personnel according to occupation and working conditions. J Epidemiol Community 
Health 1985;39(2):129-34. 
16. Teitelman AM, Welch LS, Hellenbrand KG, Bracken MB. Effect of maternal work 
activity on preterm birth and low birth weight. Am J Epidemiol 1990;131(1):104-13. 
17. McMichael AJ, Vimpani GV, Robertson EF, Baghurst PA, Clark PD. The Port Pirie 
cohort study: maternal blood lead and pregnancy outcome. J Epidemiol Community 
Health 1986;40(1):18-25. 
18. Savitz DA, Whelan EA, Kleckner RC. Effect of parents' occupational exposures on risk 
of stillbirth, preterm delivery, and small-for-gestational-age infants. Am J Epidemiol 
1989;129(6):1201-18. 
19. Bobak M. Outdoor air pollution, low birth weight, and prematurity. Environ Health 
Perspect 2000;108(2):173-6. 
20. Gouveia N, Bremner SA, Novaes HM. Association between ambient air pollution and 
birth weight in Sao Paulo, Brazil. J Epidemiol Community Health 2004;58(1):11-7. 
21. Ha EH, Hong YC, Lee BE, Woo BH, Schwartz J, Christiani DC. Is air pollution a risk 
factor for low birth weight in Seoul? Epidemiology 2001;12(6):643-8. 
22. Huynh M, Woodruff TJ, Parker JD, Schoendorf KC. Relationships between air pollution 
and preterm birth in California. Paediatr Perinat Epidemiol 2006;20(6):454-61. 
23. Lee BE, Ha EH, Park HS, Kim YJ, Hong YC, Kim H, Lee JT. Exposure to air pollution 
during different gestational phases contributes to risks of low birth weight. Hum Reprod 
2003;18(3):638-43. 
24. Lee SJ, Hajat S, Steer PJ, Filippi V. A time-series analysis of any short-term effects of 
meteorological and air pollution factors on preterm births in London, UK. Environ Res 
2008;106(2):185-94. 
25. Liu S, Krewski D, Shi Y, Chen Y, Burnett RT. Association between gaseous ambient air 
pollutants and adverse pregnancy outcomes in Vancouver, Canada. Environ Health 
Perspect 2003;111(14):1773-8. 
26. Ritz B, Wilhelm M, Hoggatt KJ, Ghosh JK. Ambient air pollution and preterm birth in 
the environment and pregnancy outcomes study at the University of California, Los 
Angeles. Am J Epidemiol 2007;166(9):1045-52. 
27. Ritz B, Yu F, Chapa G, Fruin S. Effect of air pollution on preterm birth among children 
born in Southern California between 1989 and 1993. Epidemiology 2000;11(5):502-11. 
28. Wilhelm M, Ritz B. Local variations in CO and particulate air pollution and adverse birth 
outcomes in Los Angeles County, California, USA. Environ Health Perspect 
2005;113(9):1212-21. 
29. Xu X, Ding H, Wang X. Acute effects of total suspended particles and sulfur dioxides on 
preterm delivery: a community-based cohort study. Arch Environ Health 1995;50(6):407-
15. 
30. Forbes LJ, Patel MD, Rudnicka AR, Cook DG, Bush T, Stedman JR, Whincup PH, 
Strachan DP, Anderson RH. Chronic exposure to outdoor air pollution and markers of 
systemic inflammation. Epidemiology 2009;20(2):245-53. 
31. Steinvil A, Kordova-Biezuner L, Shapira I, Berliner S, Rogowski O. Short-term exposure 
to air pollution and inflammation-sensitive biomarkers. Environ Res 2008;106(1):51-61. 
32. Woodruff TJ, Parker JD, Darrow LA, Slama R, Bell ML, Choi H, Glinianaia S, Hoggatt 
KJ, Karr CJ, Lobdell DT, Wilhelm M. Methodological issues in studies of air pollution 
and reproductive health. Environ Res 2009;109(3):311-20. 
104 
33. Yi O, Kim H, Ha E. Does area level socioeconomic status modify the effects of PM(10) 
on preterm delivery? Environ Res;110(1):55-61. 
34. Llop S, Ballester F, Estarlich M, Esplugues A, Rebagliato M, Iniguez C. Preterm birth 
and exposure to air pollutants during pregnancy. Environ Res;110(8):778-85. 
35. Ritz B, Yu F. The effect of ambient carbon monoxide on l ow birth weight among 
children born in southern California between 1989 a nd 1993. Environ Health Perspect 
1999;107(1):17-25. 
36. Maisonet M, Bush TJ, Correa A, Jaakkola JJ. Relation between ambient air pollution and 
low birth weight in the Northeastern United States. Environ Health Perspect 2001;109 
Suppl 3:351-6. 
37. Alderman BW, Baron AE, Savitz DA. Maternal exposure to neighborhood carbon 
monoxide and risk of low infant birth weight. Public Health Rep 1987;102(4):410-4. 
38. Parker JD, Woodruff TJ, Basu R, Schoendorf KC. Air pollution and birth weight among 
term infants in California. Pediatrics 2005;115(1):121-8. 
39. Chen L, Yang W, Jennison BL, Goodrich A, Omaye ST. Air pollution and birth weight in 
northern Nevada, 1991-1999. Inhal Toxicol 2002;14(2):141-57. 
40. Silbergeld EK, Patrick TE. Environmental exposures, toxicologic mechanisms, and 
adverse pregnancy outcomes. Am J Obstet Gynecol 2005;192(5 Suppl):S11-21. 
41. Crudra MW. a prospective study of periconceptional ambient air pollutant exposures and 
preeclampsia risk. international Society of Environmental Epidemiology. Paris, 2006. 
42. Bobak M, Leon DA. Pregnancy outcomes and outdoor air pollution: an ecological study 
in districts of the Czech Republic 1986-8. Occup Environ Med 1999;56(8):539-43. 
43. Wang X, Ding H, Ryan L, Xu X. Association between air pollution and low birth weight: 
a community-based study. Environ Health Perspect 1997;105(5):514-20. 
44. Brenner H, Savitz DA, Jockel KH, Greenland S. Effects of nondifferential exposure 
misclassification in ecologic studies. Am J Epidemiol 1992;135(1):85-95. 
45. Leem JH, Kaplan BM, Shim YK, Pohl HR, Gotway CA, Bullard SM, Rogers JF, Smith 
MM, Tylenda CA. Exposures to air pollutants during pregnancy and preterm delivery. 
Environ Health Perspect 2006;114(6):905-10. 
46. Rogers JF, Dunlop AL. Air pollution and very low birth weight infants: a target 
population? Pediatrics 2006;118(1):156-64. 
47. Hamby DM. The Gaussian atmospheric transport model and its sensitivity to the joint 
frequency distribution and parametric variability. Health Phys 2002;82(1):64-73. 
48. Holland JZ. A meterological survey of the oak ridge area: final report covering the period 
1948–1952.  USAEC report ORO-99., 1953. 
49. Hanna SR, & Briggs, G.A,. National Technical Information Service Handbook on 
Atmospheric Diffusion Springfield. VA: US Department of Commerce., 1982. 
50. Rogers JF, Killough GG, Thompson SJ, Addy CL, McKeown RE, Cowen DJ. Estimating 
environmental exposures to sulfur dioxide from multiple industrial sources for a case-
control study. J Expo Anal Environ Epidemiol 1999;9(6):535-45. 
51. Jerrett M, Arain A, Kanaroglou P, Beckerman B, Potoglou D, Sahsuvaroglu T, Morrison 
J, Giovis C. A review and evaluation of intraurban air pollution exposure models. J Expo 
Anal Environ Epidemiol 2005;15(2):185-204. 
52. Kannan S, Misra DP, Dvonch JT, Krishnakumar A. Exposures to airborne particulate 
matter and adverse perinatal outcomes: a b iologically plausible mechanistic framework 
105 
for exploring potential effect modification by nutrition. Environ Health Perspect 
2006;114(11):1636-42. 
53. Dejmek J, Selevan SG, Benes I, Solansky I, Sram RJ. Fetal growth and maternal 
exposure to particulate matter during pregnancy. Environ Health Perspect 
1999;107(6):475-80. 
54. Dejmek J, Solansky I, Benes I, Lenicek J, Sram RJ. The impact of polycyclic aromatic 
hydrocarbons and fine particles on pregnancy outcome. Environ Health Perspect 
2000;108(12):1159-64. 
55. Perera FP, Jedrychowski W, Rauh V, Whyatt RM. Molecular epidemiologic research on 
the effects of environmental pollutants on the fetus. Environ Health Perspect 1999;107 
Suppl 3:451-60. 
56. Perera FP, Whyatt RM, Jedrychowski W, Rauh V, Manchester D, Santella RM, Ottman 
R. Recent developments in molecular epidemiology: A study of the effects of 
environmental polycyclic aromatic hydrocarbons on bi rth outcomes in Poland. Am J 
Epidemiol 1998;147(3):309-14. 
57. Slama R, Darrow L, Parker J, Woodruff TJ, Strickland M, Nieuwenhuijsen M, Glinianaia 
S, Hoggatt KJ, Kannan S, Hurley F, Kalinka J, Sram R, Brauer M, Wilhelm M, Heinrich 
J, Ritz B. Meeting report: atmospheric pollution and human reproduction. Environ Health 
Perspect 2008;116(6):791-8. 
58. Engel SA, Erichsen HC, Savitz DA, Thorp J, Chanock SJ, Olshan AF. Risk of 
spontaneous preterm birth is associated with common proinflammatory cytokine 
polymorphisms. Epidemiology 2005;16(4):469-77. 
59. Davies JM, Latto IP, Jones JG, Veale A, Wardrop CA. Effects of stopping smoking for 
48 hours on oxygen availability from the blood: a study on pregnant women. Br Med J 
1979;2(6186):355-6. 
60. Behrman RE, Fisher DE, Paton J. Air pollution in nurseries: correlation with a decrease 
in oxygen-carrying capacity of hemoglobin. J Pediatr 1971;78(6):1050-4. 
61. Longo LD. The biological effects of carbon monoxide on the pregnant woman, fetus, and 
newborn infant. Am J Obstet Gynecol 1977;129(1):69-103. 
62. Wouters EJ, de Jong PA, Cornelissen PJ, Kurver PH, van Oel WC, van Woensel CL. 
Smoking and low birth weight: absence of influence by carbon monoxide? Eur J Obstet 
Gynecol Reprod Biol 1987;25(1):35-41. 
63. Seaton A, Soutar A, Crawford V, Elton R, McNerlan S, Cherrie J, Watt M, Agius R, 
Stout R. Particulate air pollution and the blood. Thorax 1999;54(11):1027-32. 
64. Peters A, Frohlich M, Doring A, Immervoll T, Wichmann HE, Hutchinson WL, Pepys 
MB, Koenig W. Particulate air pollution is associated with an acute phase response in 
men; results from the MONICA-Augsburg Study. Eur Heart J 2001;22(14):1198-204. 
65. Zeka A, Sullivan JR, Vokonas PS, Sparrow D, Schwartz J. Inflammatory markers and 
particulate air pollution: characterizing the pathway to disease. Int J Epidemiol 
2006;35(5):1347-54. 
66. Pope CA, 3rd, Hansen ML, Long RW, Nielsen KR, Eatough NL, Wilson WE, Eatough 
DJ. Ambient particulate air pollution, heart rate variability, and blood markers of 
inflammation in a panel of elderly subjects. Environ Health Perspect 2004;112(3):339-45. 
67. Barraza-Villarreal A, Sunyer J, Hernandez-Cadena L, Escamilla-Nunez MC, Sienra-
Monge JJ, Ramirez-Aguilar M, Cortez-Lugo M, Holguin F, Diaz-Sanchez D, Olin AC, 
106 
Romieu I. Air pollution, airway inflammation, and lung function in a cohort study of 
Mexico City schoolchildren. Environ Health Perspect 2008;116(6):832-8. 
68. Delfino RJ, Staimer N, Tjoa T, Polidori A, Arhami M, Gillen DL, Kleinman MT, Vaziri 
ND, Longhurst J, Zaldivar F, Sioutas C. Circulating biomarkers of inflammation, 
antioxidant activity, and platelet activation are associated with primary combustion 
aerosols in subjects with coronary artery disease. Environ Health Perspect 
2008;116(7):898-906. 
69. Ruckerl R, Ibald-Mulli A, Koenig W, Schneider A, Woelke G, Cyrys J, Heinrich J, 
Marder V, Frampton M, Wichmann HE, Peters A. Air pollution and markers of 
inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit 
Care Med 2006;173(4):432-41. 
70. Williams LA, Ulrich CM, Larson T, Wener MH, Wood B, Campbell PT, Potter JD, 
McTiernan A, De Roos AJ. Proximity to traffic, inflammation, and immune function 
among women in the Seattle, Washington, area. Environ Health Perspect 
2009;117(3):373-8. 
71. Ablij H, Meinders A. C-reactive protein: history and revival. Eur J Intern Med 
2002;13(7):412. 
72. Devaraj S, O'Keefe G, Jialal I. Defining the proinflammatory phenotype using high 
sensitive C-reactive protein levels as the biomarker. J Clin Endocrinol Metab 
2005;90(8):4549-54. 
73. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive 
protein and the risk of future cardiovascular events among apparently healthy women. 
Circulation 1998;98(8):731-3. 
74. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive 
protein levels in overweight and obese adults. JAMA 1999;282(22):2131-5. 
75. Sacks GP, Seyani L, Lavery S, Trew G. Maternal C-reactive protein levels are raised at 4 
weeks gestation. Hum Reprod 2004;19(4):1025-30. 
76. Larsson A, Palm M, Hansson LO, Basu S, Axelsson O. Reference values for alpha1-acid 
glycoprotein, alpha1-antitrypsin, albumin, haptoglobin, C-reactive protein, IgA, IgG and 
IgM during pregnancy. Acta Obstet Gynecol Scand 2008;87(10):1084-8. 
77. Fialova L, Malbohan I, Kalousova M, Soukupova J, Krofta L, Stipek S, Zima T. 
Oxidative stress and inflammation in pregnancy. Scand J Clin Lab Invest 
2006;66(2):121-7. 
78. Cicarelli LM, Perroni AG, Zugaib M, de Albuquerque PB, Campa A. Maternal and cord 
blood levels of serum amyloid A, C-reactive protein, tumor necrosis factor-alpha, 
interleukin-1beta, and interleukin-8 during and after delivery. Mediators Inflamm 
2005;2005(2):96-100. 
79. Hackney DN, Macpherson TA, Dunigan JT, Simhan HN. First-trimester maternal plasma 
concentrations of C-reactive protein in low-risk patients and the subsequent development 
of chorioamnionitis. Am J Perinatol 2008;25(7):407-11. 
80. Lohsoonthorn V, Qiu C, Williams MA. Maternal serum C-reactive protein concentrations 
in early pregnancy and subsequent risk of preterm delivery. Clin Biochem 2007;40(5-
6):330-5. 
81. Catov JM, Bodnar LM, Ness RB, Barron SJ, Roberts JM. Inflammation and dyslipidemia 
related to risk of spontaneous preterm birth. Am J Epidemiol 2007;166(11):1312-9. 
107 
82. Ghezzi F, Franchi M, Raio L, Di Naro E, Bossi G, D'Eril GV, Bolis P. Elevated amniotic 
fluid C-reactive protein at the time of genetic amniocentesis is a m arker for preterm 
delivery. Am J Obstet Gynecol 2002;186(2):268-73. 
83. Boggess KA, Lieff S, Murtha AP, Moss K, Jared H, Beck J, Offenbacher S. Maternal 
serum C-reactive protein concentration early in pregnancy and subsequent pregnancy 
loss. Am J Perinatol 2005;22(6):299-304. 
84. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, 3rd, Criqui M, Fadl 
YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Jr., Taubert K, Tracy RP, 
Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical 
and public health practice: A statement for healthcare professionals from the Centers for 
Disease Control and Prevention and the American Heart Association. Circulation 
2003;107(3):499-511. 
85. Shima M. Air pollution and serum C-reactive protein concentration in children. J 
Epidemiol 2007;17(5):169-76. 
86. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, 
Pepys MB, Gudnason V. C-reactive protein and other circulating markers of 
inflammation in the prediction of coronary heart disease. N Engl J Med 
2004;350(14):1387-97. 
87. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of 
inflammation in the prediction of cardiovascular disease in women. N Engl J Med 
2000;342(12):836-43. 
88. Riediker M, Cascio WE, Griggs TR, Herbst MC, Bromberg PA, Neas L, Williams RW, 
Devlin RB. Particulate matter exposure in cars is associated with cardiovascular effects in 
healthy young men. Am J Respir Crit Care Med 2004;169(8):934-40. 
89. Bell ML, Ebisu K, Belanger K. Ambient air pollution and low birth weight in 
Connecticut and Massachusetts. Environ Health Perspect 2007;115(7):1118-24. 
90. Ritz B, Wilhelm M, Zhao Y. Air pollution and infant death in southern California, 1989-
2000. Pediatrics 2006;118(2):493-502. 
91. Ritz B, Yu F, Fruin S, Chapa G, Shaw GM, Harris JA. Ambient air pollution and risk of 
birth defects in Southern California. Am J Epidemiol 2002;155(1):17-25. 
92. Wu J, Ren C, Delfino RJ, Chung J, Wilhelm M, Ritz B. Association between local 
traffic-generated air pollution and preeclampsia and preterm delivery in the south coast 
air basin of California. Environ Health Perspect 2009;117(11):1773-9. 
93. Ritz B, Wilhelm M. Ambient air pollution and adverse birth outcomes: methodologic 
issues in an emerging field. Basic Clin Pharmacol Toxicol 2008;102(2):182-90. 
94. de Medeiros AP, Gouveia N, Machado RP, de Souza MR, Alencar GP, Novaes HM, de 
Almeida MF. Traffic-related air pollution and perinatal mortality: a case-control study. 
Environ Health Perspect 2009;117(1):127-32. 
95. Wilhelm M, Ritz B. Residential proximity to traffic and adverse birth outcomes in Los 
Angeles county, California, 1994-1996. Environ Health Perspect 2003;111(2):207-16. 
96. Donaldson K, Stone V, Seaton A, MacNee W. Ambient particle inhalation and the 
cardiovascular system: potential mechanisms. Environ Health Perspect 2001;109 Suppl 
4:523-7. 
97. Schins RP, Lightbody JH, Borm PJ, Shi T, Donaldson K, Stone V. Inflammatory effects 
of coarse and fine particulate matter in relation to chemical and biological constituents. 
Toxicol Appl Pharmacol 2004;195(1):1-11. 
108 
98. Saldiva PH, Clarke RW, Coull BA, Stearns RC, Lawrence J, Murthy GG, Diaz E, 
Koutrakis P, Suh H, Tsuda A, Godleski JJ. Lung inflammation induced by concentrated 
ambient air particles is related to particle composition. Am J Respir Crit Care Med 
2002;165(12):1610-7. 
99. Saber AT, Bornholdt J, Dybdahl M, Sharma AK, Loft S, Vogel U, Wallin H. Tumor 
necrosis factor is not required for particle-induced genotoxicity and pulmonary 
inflammation. Arch Toxicol 2005;79(3):177-82. 
100. Dubowsky SD, Suh H, Schwartz J, Coull BA, Gold DR. Diabetes, obesity, and 
hypertension may enhance associations between air pollution and markers of systemic 
inflammation. Environ Health Perspect 2006;114(7):992-8. 
101. Thornton CA. Immunology of pregnancy. Proc Nutr Soc 2010;69(3):357-65. 
102. Hubel CA, Powers RW, Snaedal S, Gammill HS, Ness RB, Roberts JM, Arngrimsson R. 
C-reactive protein is elevated 30 years after eclamptic pregnancy. Hypertension 
2008;51(6):1499-505. 
103. DeIaco S, Myers DE, Posa D. Space-time analysis using a general product-sum model. 
Statistics & Probability Letters 2001;52:21-28. 
104. Gething P, Atkinson P, Noor A, Gikandi P, Hay S, Nixon M. A local space-time kriging 
approach applied to a national outpatient malaria dataset. Comput Geosci 
2007;33(10):1337-1350. 
105. Mickey RM, Greenland S. The impact of confounder selection criteria on effect 
estimation. Am J Epidemiol 1989;129(1):125-37. 
106. Hoffmann B, Moebus S, Dragano N, Stang A, Mohlenkamp S, Schmermund A, 
Memmesheimer M, Brocker-Preuss M, Mann K, Erbel R, Jockel KH. Chronic residential 
exposure to particulate matter air pollution and systemic inflammatory markers. Environ 
Health Perspect 2009;117(8):1302-8. 
107. Panasevich S, Leander K, Rosenlund M, Ljungman P, Bellander T, de Faire U, Pershagen 
G, Nyberg F. Associations of long- and short-term air pollution exposure with markers of 
inflammation and coagulation in a population sample. Occup Environ Med 
2009;66(11):747-53. 
108. Thompson AM, Zanobetti A, Silverman F, Schwartz J, Coull B, Urch B, Speck M, Brook 
JR, Manno M, Gold DR. Baseline repeated measures from controlled human exposure 
studies: associations between ambient air pollution exposure and the systemic 
inflammatory biomarkers IL-6 and fibrinogen. Environ Health Perspect 2010;118(1):120-
4. 
109. Risom L, Moller P, Loft S. Oxidative stress-induced DNA damage by particulate air 
pollution. Mutat Res 2005;592(1-2):119-37. 
110. Rudez G, Janssen NA, Kilinc E, Leebeek FW, Gerlofs-Nijland ME, Spronk HM, ten Cate 
H, Cassee FR, de Maat MP. Effects of ambient air pollution on he mostasis and 
inflammation. Environ Health Perspect 2009;117(6):995-1001. 
111. Amarilyo G, Oren A, Mimouni FB, Ochshorn Y, Deutsch V, Mandel D. Increased cord 
serum inflammatory markers in small-for-gestational-age neonates. J Perinatol 2010. 
112. Chen L, Bell EM, Caton AR, Druschel CM, Lin S. Residential mobility during pregnancy 
and the potential for ambient air pollution exposure misclassification. Environ Res 
2010;110(2):162-8. 
113. Joseph KS, Kramer MS. Review of the evidence on fetal and early childhood antecedents 
of adult chronic disease. Epidemiol Rev 1996;18(2):158-74. 
109 
114. Selling KE, Carstensen J, Finnstrom O, Josefsson A, Sydsjo G. Hospitalizations in 
adolescence and early adulthood among Swedish men and women born preterm or small 
for gestational age. Epidemiology 2008;19(1):63-70. 
115. Einarson A, Riordan S. Smoking in pregnancy and lactation: a review of risks and 
cessation strategies. Eur J Clin Pharmacol 2009;65(4):325-30. 
116. Engel SM, Janevic TM, Stein CR, Savitz DA. Maternal smoking, preeclampsia, and 
infant health outcomes in New York City, 1995-2003. Am J Epidemiol 2009;169(1):33-
40. 
117. Fantuzzi G, Aggazzotti G, Righi E, Facchinetti F, Bertucci E, Kanitz S, Barbone F, 
Sansebastiano G, Battaglia MA, Leoni V, Fabiani L, Triassi M, Sciacca S. Preterm 
delivery and exposure to active and passive smoking during pregnancy: a case-control 
study from Italy. Paediatr Perinat Epidemiol 2007;21(3):194-200. 
118. Odendaal HJ, Steyn DW, Elliott A, Burd L. Combined effects of cigarette smoking and 
alcohol consumption on perinatal outcome. Gynecol Obstet Invest 2009;67(1):1-8. 
119. Shah NR, Bracken MB. A systematic review and meta-analysis of prospective studies on 
the association between maternal cigarette smoking and preterm delivery. Am J Obstet 
Gynecol 2000;182(2):465-72. 
120. Lain KY, Luppi P, McGonigal S, Roberts JM, DeLoia JA. Intracellular adhesion 
molecule concentrations in women who smoke during pregnancy. Obstet Gynecol 
2006;107(3):588-94. 
121. Lain KY, Wilson JW, Crombleholme WR, Ness RB, Roberts JM. Smoking during 
pregnancy is associated with alterations in markers of endothelial function. Am J Obstet 
Gynecol 2003;189(4):1196-201. 
122. Luppi P, Lain KY, Jeyabalan A, DeLoia JA. The effects of cigarette smoking on 
circulating maternal leukocytes during pregnancy. Clin Immunol 2007;122(2):214-9. 
123. Simhan HN, Caritis SN, Hillier SL, Krohn MA. Cervical anti-inflammatory cytokine 
concentrations among first-trimester pregnant smokers. Am J Obstet Gynecol 
2005;193(6):1999-2003. 
124. Judd CM, Kenny DA. Estimating the effects of social interventions. New York: 
Cambridge University Press, 1981. 
125. Lindqvist R, Lendahls L, Tollbom O, Aberg H, Hakansson A. Smoking during 
pregnancy: comparison of self-reports and cotinine levels in 496 w omen. Acta Obstet 
Gynecol Scand 2002;81(3):240-4. 
126. Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM. Relation between markers of 
systemic vascular inflammation and smoking in women. Am J Cardiol 2002;89(9):1117-
9. 
127. Frohlich M, Sund M, Lowel H, Imhof A, Hoffmeister A, Koenig W. Independent 
association of various smoking characteristics with markers of systemic inflammation in 
men. Results from a r epresentative sample of the general population (MONICA 
Augsburg Survey 1994/95). Eur Heart J 2003;24(14):1365-72. 
128. Helmersson J, Larsson A, Vessby B, Basu S. Active smoking and a history of smoking 
are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane 
formation in elderly men. Atherosclerosis 2005;181(1):201-7. 
129. Lowe GD, Yarnell JW, Rumley A, Bainton D, Sweetnam PM. C-reactive protein, fibrin 
D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation 
110 
and fibrin turnover linked in pathogenesis? Arterioscler Thromb Vasc Biol 
2001;21(4):603-10. 
130. Ohsawa M, Okayama A, Nakamura M, Onoda T, Kato K, Itai K, Yoshida Y, Ogawa A, 
Kawamura K, Hiramori K. CRP levels are elevated in smokers but unrelated to the 
number of cigarettes and are decreased by long-term smoking cessation in male smokers. 
Prev Med 2005;41(2):651-6. 
131. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. 
Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and 
haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 
2005;26(17):1765-73. 
132. Speer P, Zhang Y, Gu Y, Lucas MJ, Wang Y. Effects of nicotine on i ntercellular 
adhesion molecule expression in endothelial cells and integrin expression in neutrophils 
in vitro. Am J Obstet Gynecol 2002;186(3):551-6. 
133. Dietz PM, Homa D, England LJ, Burley K, Tong VT, Dube SR, Bernert JT. Estimates of 
Nondisclosure of Cigarette Smoking Among Pregnant and Nonpregnant Women of 
Reproductive Age in the United States. Am J Epidemiol 2010. 
134. Chung SJ, Kwon YJ, Park MC, Park YB, Lee SK. The Correlation between Increased 
Serum Concentrations of Interleukin-6 Family Cytokines and Disease Activity in 
Rheumatoid Arthritis Patients. Yonsei Med J 2011;52(1):113-20. 
135. Sheldon J, Riches P, Gooding R, Soni N, Hobbs JR. C-reactive protein and its cytokine 
mediators in intensive-care patients. Clin Chem 1993;39(1):147-50. 
136. Chesley L. Hypertensive disorders in pregnancy. New York: Appleton-Century-Crofts 
1978. 
137. Laragh J, Brenner B, eds. Pathophysiology of preeclampsia. Vol. 142 New York: Raven 
Press, 1995. 
138. Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of preeclampsia 
and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 1990;163(2):460-5. 
139. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med 
1998;339(5):313-20. 
140. Xiong X, Mayes D, Demianczuk N, Olson DM, Davidge ST, Newburn-Cook C, Saunders 
LD. Impact of pregnancy-induced hypertension on f etal growth. Am J Obstet Gynecol 
1999;180(1 Pt 1):207-13. 
141. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers 
after pre-eclampsia: population based cohort study. BMJ 2001;323(7323):1213-7. 
142. Auchincloss AH, Diez Roux AV, Dvonch JT, Brown PL, Barr RG, Daviglus ML, Goff 
DC, Kaufman JD, O'Neill MS. Associations between recent exposure to ambient fine 
particulate matter and blood pressure in the Multi-ethnic Study of Atherosclerosis 
(MESA). Environ Health Perspect 2008;116(4):486-91. 
143. Zanobetti A, Canner MJ, Stone PH, Schwartz J, Sher D, Eagan-Bengston E, Gates KA, 
Hartley LH, Suh H, Gold DR. Ambient pollution and blood pressure in cardiac 
rehabilitation patients. Circulation 2004;110(15):2184-9. 
144. Ebelt ST, Wilson WE, Brauer M. Exposure to ambient and nonambient components of 
particulate matter: a comparison of health effects. Epidemiology 2005;16(3):396-405. 
145. Harrabi I, Rondeau V, Dartigues JF, Tessier JF, Filleul L. Effects of particulate air 
pollution on systolic blood pressure: A population-based approach. Environ Res 
2006;101(1):89-93. 
111 
146. Ibald-Mulli A, Timonen KL, Peters A, Heinrich J, Wolke G, Lanki T, Buzorius G, 
Kreyling WG, de Hartog J, Hoek G, ten Brink HM, Pekkanen J. Effects of particulate air 
pollution on blood pressure and heart rate in subjects with cardiovascular disease: a 
multicenter approach. Environ Health Perspect 2004;112(3):369-77. 
147. Jansen KL, Larson TV, Koenig JQ, Mar TF, Fields C, Stewart J, Lippmann M. 
Associations between health effects and particulate matter and black carbon in subjects 
with respiratory disease. Environ Health Perspect 2005;113(12):1741-6. 
148. Madsen C, Nafstad P. Associations between environmental exposure and blood pressure 
among participants in the Oslo Health Study (HUBRO). Eur J Epidemiol 2006;21(7):485-
91. 
149. Blackburn S. Maternal, Fetal, and Neonatal Physiology: A Clinical Perspective. St. 
Louis: Mo: Saunders, 2003. 
150. Luppi CJ. Cardiopulmonary resuscitation in pregnancy. What all nurses caring for 
childbearing women need to know. AWHONN Lifelines 1999;3(3):41-5. 
151. Torgersen KL, Curran CA. A systematic approach to the physiologic adaptations of 
pregnancy. Crit Care Nurs Q 2006;29(1):2-19. 
152. Clapp JF, 3rd, Seaward BL, Sleamaker RH, Hiser J. Maternal physiologic adaptations to 
early human pregnancy. Am J Obstet Gynecol 1988;159(6):1456-60. 
153. Duvekot JJ, Peeters LL. Maternal cardiovascular hemodynamic adaptation to pregnancy. 
Obstet Gynecol Surv 1994;49(12 Suppl):S1-14. 
154. Rudra C, Williams M. A prospective study of periconcep¬tional ambient air pollutant 
exposures and preeclampsia risk. Vol. 17 Epidemiology 2006;S104–S105. 
155. Woodruff T, Morello-Frosch R, Jesdale B. Air pollution and preeclampsia among 
pregnant women in California, 1996–2004 Vol. 19 Epidemiology, 2008;S310. 
156. van den Hooven EH, de Kluizenaar Y, Pierik FH, Hofman A, van Ratingen SW, 
Zandveld PY, Mackenbach JP, Steegers EA, Miedema HM, Jaddoe VW. Air Pollution, 
Blood Pressure, and the Risk of Hypertensive Complications During Pregnancy: The 
Generation R Study. Hypertension 2011. 
157. DeCesare L, Myers DE, Posa D. Product-sum covariance for space-time modeling: an 
environmental application. Envirometrics 2001;12:11-23. 
158. Bakker R, Steegers EA, Mackenbach JP, Hofman A, Jaddoe VW. Maternal smoking and 
blood pressure in different trimesters of pregnancy: the Generation R study. J Hypertens 
2010;28(11):2210-8. 
159. Matkin CC, Britton J, Samuels S, Eskenazi B. Smoking and blood pressure patterns in 
normotensive pregnant women. Paediatr Perinat Epidemiol 1999;13(1):22-34. 
160. Brook RD, Rajagopalan S. Particulate matter, air pollution, and blood pressure. J Am Soc 
Hypertens 2009;3(5):332-50. 
161. Urch B, Silverman F, Corey P, Brook JR, Lukic KZ, Rajagopalan S, Brook RD. Acute 
blood pressure responses in healthy adults during controlled air pollution exposures. 
Environ Health Perspect 2005;113(8):1052-5. 
162. Shah PS, Balkhair T. Air pollution and birth outcomes: A systematic review. Environ Int 
2010. 
163. Ray JG, Burrows RF, Burrows EA, Vermeulen MJ. MOS HIP: McMaster outcome study 
of hypertension in pregnancy. Early Hum Dev 2001;64(2):129-43. 
164. Xiong X, Fraser WD. Impact of pregnancy-induced hypertension on birthweight by 
gestational age. Paediatr Perinat Epidemiol 2004;18(3):186-91. 
112 
165. Zhang J, Villar J, Sun W, Merialdi M, Abdel-Aleem H, Mathai M, Ali M, Yu KF, 
Zavaleta N, Purwar M, Nguyen TN, Campodonico L, Landoulsi S, Lindheimer M, 
Carroli G. Blood pressure dynamics during pregnancy and spontaneous preterm birth. 
Am J Obstet Gynecol 2007;197(2):162 e1-6. 
166. Bukowski R, Smith GC, Malone FD, Ball RH, Nyberg DA, Comstock CH, Hankins GD, 
Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, 
D'Alton ME. Fetal growth in early pregnancy and risk of delivering low birth weight 
infant: prospective cohort study. BMJ 2007;334(7598):836. 
167. Mook-Kanamori DO, Steegers EA, Eilers PH, Raat H, Hofman A, Jaddoe VW. Risk 
factors and outcomes associated with first-trimester fetal growth restriction. JAMA 
2010;303(6):527-34. 
168. Smith GC, Smith MF, McNay MB, Fleming JE. First-trimester growth and the risk of 
low birth weight. N Engl J Med 1998;339(25):1817-22. 
 
 
